Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763082	pf-ld	u/l (u/l)	3066	3997	0.20%
40763082	pf-ld	— (—)	259	280	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

626

981

5.76

317.49

1.3

445.59

409.75

u/l

0.22

593

913

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

495

564

7.67

316.90

1.2

1.3

733.12

285.76

u/l

2.64

483

526

Other bacterial diseases

1057

1921

3.86

309.22

1.3

663.92

412.51

u/l

1.79

993

1834

All-cause Heart Failure

953

1405

5.03

307.65

1.4

1.3

343.58

588.17

u/l

1.86

903

1331

All pneumoniae

1242

1576

5.53

307.65

1.3

626.63

383.17

u/l

2.40

1179

1493

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

617

641

8.50

307.65

1.3

681.34

313.23

u/l

2.69

601

599

Pneumonias (Asthma/COPD co-morbidities)

1243

1578

5.55

307.65

1.3

628.09

383.05

u/l

2.42

1179

1495

Heart failure,strict

903

1060

6.34

307.65

1.4

1.3

348.02

660.72

u/l

2.36

858

1012

1148

1322

5.53

307.65

1.3

618.69

371.76

u/l

2.27

1094

1257

COPD differential diagnosis

653

319

10.36

307.65

1.3

1.2

384.14

295.19

u/l

1.00

624

295

Influenza and pneumonia

1234

1545

5.33

307.65

1.3

629.01

384.97

u/l

2.37

1168

1469

Heart failure, not strict

1041

1342

5.46

307.65

1.4

1.3

388.79

647.53

u/l

2.10

981

1282

COPD (mode)

386

240

13.07

307.65

1.3

1.2

707.90

294.25

u/l

1.38

366

222

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1148

1322

5.53

307.65

1.3

618.69

371.76

u/l

2.27

1094

1257

Other diseases of pleura

2019

784

25.10

307.65

1.4

1.2

409.56

606.23

u/l

0.95

1937

722

Asthma, unspecified (mode), excluding more controls

345

179

15.29

307.65

1.4

1.2

639.80

388.70

u/l

0.59

322

162

Other pleural conditions

832

181

57.49

307.65

1.5

1.2

410.12

329.81

u/l

0.80

801

171

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1240

1594

5.56

307.65

1.3

631.24

382.93

u/l

2.47

1176

1511

Heart failure, strict

986

1427

5.12

307.65

1.4

1.3

335.50

591.11

u/l

2.09

935

1352

Pyothorax

288

141

24.97

307.65

1.4

1935.48

326.02

u/l

5.12

271

136

ILD differential diagnosis

652

319

10.34

307.65

1.3

1.2

384.01

295.19

u/l

1.00

623

295

Pleural effusion

1531

286

70.31

307.65

1.5

1.2

398.27

324.30

u/l

0.99

1478

266

Pneumonia, organism unspecified

1194

1520

5.79

307.65

1.3

594.90

378.12

u/l

2.07

1136

1447

Lung cancer and mesothelioma

588

174

30.88

307.65

1.3

1.2

684.63

328.37

u/l

1.78

575

166

Excluding asthma or asthma-COPD overlap

656

319

10.41

307.65

1.3

1.2

384.32

295.04

u/l

1.01

626

295

Suppurative and necrotic conditions of lower respiratory tract

314

181

20.36

307.65

1.4

1.3

1814.86

318.26

u/l

5.23

295

175

Other pulmonary diagnosis

677

319

10.75

307.65

1.3

1.2

382.25

295.04

u/l

0.98

643

295

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

390

431

8.99

299.63

1.3

634.46

296.55

u/l

3.44

381

398

Asthma, excluding more controls

422

186

12.18

286.54

1.4

1.2

629.53

398.42

u/l

0.64

398

169

Bacterial infection, other or unspecified

752

1574

4.41

284.33

1.4

1.3

539.36

384.64

u/l

1.12

708

1502

Heart failure and antihypertensive medication

440

340

8.81

280.54

1.5

1.2

335.52

813.80

u/l

2.05

419

322

Abnormal findings on diagnostic imaging of lung

743

1753

4.23

272.32

1.4

1.3

544.00

452.74

u/l

0.40

709

1651

Dyspnoea

990

2136

3.60

272.03

1.4

1.3

436.93

502.73

u/l

0.48

945

2012

Asthma, unspecified (mode)

362

305

9.50

271.38

1.4

1.2

630.31

290.77

u/l

1.03

338

281

Other medical care

634

1340

4.74

268.56

1.4

1.3

419.72

495.12

u/l

0.49

610

1259

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

841

2078

3.82

265.59

1.4

1.3

532.81

454.67

u/l

0.38

801

1960

Asthma (only as main-diagnosis), excluding more controls

360

186

11.61

257.19

1.4

1.2

427.62

398.42

u/l

0.11

332

169

Malignant neoplasm of respiratory system and intrathoracic organs

506

891

5.46

243.87

1.3

724.03

382.90

u/l

1.61

496

836

Renal tubulo-interstitial diseases

915

2066

3.44

235.47

1.3

428.16

508.97

u/l

0.43

856

1969

Later onset COPD, excluding more controls

278

190

11.73

234.58

1.3

1.2

593.93

307.25

u/l

1.13

261

175

Diseases of the respiratory system

469

319

7.43

228.39

1.4

1.1

351.85

313.56

u/l

0.31

451

296

Non-ischemic cardiomyopathy

490

769

5.39

225.53

1.4

1.3

471.86

561.39

u/l

0.22

463

732

Asthma

439

318

7.46

223.21

1.4

1.2

633.76

295.60

u/l

1.30

415

294

Non-small cell lung cancer

390

695

5.90

209.53

1.3

634.46

387.97

u/l

1.63

381

654

Renal failure

673

1657

3.80

209.32

1.4

1.3

242.01

516.25

u/l

5.63

622

1575

Asthma (mode)

414

319

7.18

207.41

1.4

1.2

496.35

295.19

u/l

1.43

389

295

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

948

2197

3.13

206.11

1.4

1.3

389.62

522.96

u/l

1.19

895

2082

Asthma (only as main-diagnosis)

378

318

7.22

200.40

1.4

1.2

424.29

295.60

u/l

1.01

348

294

Persons encountering health services for specific procedures and health care

945

1902

3.11

194.51

1.3

456.35

541.69

u/l

0.54

903

1786

Other heart diseases, wide

705

1170

3.77

193.51

1.4

1.2

299.04

704.88

u/l

9.22

677

1108

Bacterial Sepsis

618

1487

3.77

189.40

1.4

1.3

403.89

487.01

u/l

0.40

573

1415

Heart failure and bmi 25plus

490

718

4.82

187.22

1.4

1.3

456.29

673.63

u/l

0.61

468

674

Oxycodone

511

1215

4.16

183.39

1.4

1.3

424.92

516.90

u/l

0.53

496

1146

Implicit Sepsis

768

1881

3.22

178.73

1.4

1.3

404.38

498.85

u/l

0.57

719

1791

Valvular heart disease excluding rheumatic fever

506

858

4.38

177.78

1.4

1.3

250.82

689.26

u/l

7.61

478

810

Non-rheumatic valve diseases

505

856

4.38

177.23

1.4

1.3

250.86

690.16

u/l

7.61

477

808

Abnormalities of breathing

788

1439

3.28

174.67

1.4

1.3

451.16

548.17

u/l

0.61

744

1363

Implicit bacterial Sepsis

559

1382

3.79

173.75

1.4

1.3

383.99

486.50

u/l

0.48

518

1316

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

278

425

6.77

173.61

1.3

451.58

322.68

u/l

2.72

261

399

Other heart diseases

366

410

5.96

172.20

1.4

1.2

297.63

884.28

u/l

5.18

352

387

COPD/asthma related infections

841

1322

3.21

169.37

1.4

1.3

557.56

371.76

u/l

1.24

802

1257

COPD/asthma/ILD related infections

841

1322

3.21

169.37

1.4

1.3

557.56

371.76

u/l

1.24

802

1257

Septicaemia

523

1351

3.79

165.47

1.4

1.3

583.91

389.56

u/l

0.82

484

1287

Chronic kidney disease

470

1193

4.03

162.19

1.4

1.3

225.45

502.84

u/l

3.73

434

1134

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

703

1246

3.37

161.49

1.3

438.84

438.15

u/l

0.00

672

1162

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

702

1245

3.36

161.09

1.3

439.28

437.96

u/l

0.01

671

1161

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

322

610

5.43

160.99

1.2

1.3

484.54

314.82

u/l

1.83

310

577

Malignant neoplasm, wide definition for exclusion

702

1246

3.36

160.91

1.3

439.28

437.70

u/l

0.01

671

1162

Bacterial pneumoniae

458

993

4.15

160.53

1.3

658.16

373.91

u/l

1.42

430

947

Early onset COPD, excluding more controls

172

161

10.85

159.27

1.3

789.64

353.41

u/l

0.60

165

155

Dialysis, with operation codes

247

368

7.00

158.43

1.4

1.3

241.41

345.78

u/l

1.93

233

351

Bacterial pneumonia, not elsewhere classified

444

955

4.18

157.23

1.3

649.13

377.32

u/l

1.28

419

910

Explicit Sepsis

528

1445

3.57

152.54

1.4

1.3

577.83

482.09

u/l

0.30

489

1374

Malignant neoplasm

712

1357

3.14

147.29

1.3

447.11

424.36

u/l

0.14

680

1263

Acute renal failure

341

735

4.79

146.97

1.4

1.3

246.53

440.69

u/l

2.31

317

699

Nephropathy related operations

242

385

6.56

145.85

1.4

1.3

224.56

361.95

u/l

3.24

228

367

Other septicaemia

466

1247

3.74

145.18

1.4

1.3

580.80

377.76

u/l

0.76

431

1186

Malignant neoplasm of bronchus and lung

380

838

4.40

143.62

1.2

1.3

814.19

388.01

u/l

1.53

374

784

Condition for Implicit Sepsis (Organ dysfunction codes)

751

1954

2.82

137.50

1.4

1.3

406.19

506.40

u/l

0.62

701

1864

Non-invasive ventilation

232

352

6.30

133.55

1.5

1.2

619.20

525.48

u/l

0.13

213

337

Atrial fibrillation and flutter with reimbursement

277

296

6.10

130.95

1.4

1.2

291.10

869.45

u/l

3.89

267

278

Any gastric operation

531

739

3.63

127.83

1.3

381.63

605.76

u/l

1.45

503

698

GASTRO-related operations

531

739

3.63

127.83

1.3

381.63

605.76

u/l

1.45

503

698

Atrial fibrillation and flutter

288

339

5.62

127.39

1.4

1.2

322.04

833.17

u/l

3.87

278

318

Any event in cancer register

678

1391

2.91

124.17

1.3

446.77

430.86

u/l

0.09

651

1294

First line medication for Crohn's disease

858

1852

2.54

119.30

1.4

1.3

535.83

511.71

u/l

0.10

814

1744

Primary_lymphoid and hematopoietic malignant neoplasms

285

628

4.64

119.16

1.3

340.34

323.33

u/l

0.18

264

587

Fever of other and unknown origin

516

1569

3.08

117.89

1.3

543.95

529.89

u/l

0.04

479

1494

Aplastic and other anaemias

532

1758

2.92

110.16

1.3

390.51

481.91

u/l

0.42

502

1661

Diseases of arteries, arterioles and capillaries (FINNGEN)

233

285

5.80

109.56

1.3

1.2

393.10

783.00

u/l

1.80

222

267

Oral corticosteroids

852

2176

2.39

107.00

1.4

1.3

515.25

494.36

u/l

0.09

803

2060

Cardiac arrhythmias

393

737

3.55

102.01

1.4

1.3

316.23

695.59

u/l

5.57

379

697

Care involving dialysis

145

196

7.72

101.71

1.5

1.3

181.29

323.05

u/l

3.49

135

186

ILD medications: prednisolone, methylprednisolone, prednisone

842

2037

2.35

100.55

1.4

1.3

524.18

496.33

u/l

0.11

799

1925

Ascites

147

207

7.44

99.56

1.3

337.25

322.11

u/l

0.08

138

197

Cardiomyopathy

202

400

5.16

96.09

1.4

1.3

428.59

676.16

u/l

0.47

189

379

Other anaemias

485

1675

2.84

96.07

1.3

412.48

485.15

u/l

0.28

458

1584

Other and unspecified anaemias

481

1665

2.84

95.41

1.3

412.83

487.10

u/l

0.29

454

1574

Bacterial pneumonia (organism specified)

484

1571

2.84

95.25

1.4

1.3

643.00

416.63

u/l

1.08

455

1490

Inflammatory bowel disease treatment related agents

860

2183

2.25

93.44

1.4

1.3

508.00

494.80

u/l

0.05

814

2066

ILD medications

838

2039

2.27

91.85

1.4

1.3

529.37

496.93

u/l

0.13

791

1927

Certain infectious and parasitic diseases

679

1414

2.42

83.27

1.4

1.3

338.96

430.21

u/l

2.06

646

1347

Cerebrovascular diseases (FINNGEN)

219

342

4.63

82.31

1.3

1.2

385.55

825.88

u/l

2.86

210

323

Erysipelas

475

1675

2.61

79.87

1.3

675.28

400.96

u/l

0.83

440

1599

Continuous positive airway pressure

183

328

4.89

78.23

1.3

950.79

555.00

u/l

0.47

171

313

COPD

493

1602

2.57

78.14

1.3

643.55

444.23

u/l

0.69

468

1514

Haemorrhage from respiratory passages

348

1090

3.00

76.05

1.4

1.3

327.80

533.82

u/l

1.80

332

1032

Heart failure and coronary heart disease

446

1251

2.71

75.87

1.4

1.3

216.68

445.99

u/l

3.55

415

1190

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

683

2099

2.23

75.80

1.4

1.3

354.40

562.51

u/l

2.15

649

1988

Non-allergic asthma (mode), excluding more controls

9.87

75.43

1.4

1.2

714.73

468.04

u/l

0.32

Other arrhythmias

393

1061

2.86

75.36

1.4

1.3

367.93

685.97

u/l

3.29

373

1006

Other disorders of fluid, electrolyte and acid-base balance

330

1055

3.06

75.24

1.3

539.19

521.21

u/l

0.04

317

999

Extracorporeal dialysis

118

179

6.91

74.72

1.5

1.3

165.62

343.97

u/l

5.01

108

173

Other chronic obstructive pulmonary disease

475

1565

2.56

74.57

1.3

650.19

447.95

u/l

0.67

451

1479

Benign neoplasm of colon, rectum, anus and anal canal

386

959

2.90

74.53

1.4

1.3

541.49

429.13

u/l

0.27

362

894

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

156

319

5.01

71.70

1.3

341.15

304.71

u/l

0.30

143

302

Primary_lymphoid and hematopoietic malignant neoplasms

285

901

3.22

71.24

1.3

340.34

417.54

u/l

0.66

264

851

Diseases of arteries, arterioles and capillaries

622

2097

2.24

71.01

1.3

319.34

514.41

u/l

2.71

582

1991

Metabolic disorders

687

2002

2.14

68.26

1.3

487.55

509.02

u/l

0.08

656

1890

Other chronic obstructive pulmonary disease, including avohilmo

531

1922

2.32

67.96

1.3

662.96

445.17

u/l

0.84

502

1817

COPD, hospital admissions

485

1720

2.42

67.93

1.3

1.4

646.01

451.40

u/l

0.65

460

1623

Benign neoplasm: Colon

351

948

2.86

67.57

1.4

1.3

376.04

418.58

u/l

0.22

327

887

Bleeding

668

2299

2.13

67.54

1.4

1.3

462.94

490.34

u/l

0.11

634

2170

General symptoms and signs

736

1746

2.12

67.33

1.3

483.30

520.80

u/l

0.16

691

1664

Hypertensive diseases (excluding secondary)

258

411

3.67

67.28

1.4

1.2

408.14

884.37

u/l

3.49

246

388

Cardiovascular diseases (excluding rheumatic etc)

266

431

3.58

66.96

1.4

1.2

393.07

870.34

u/l

3.82

253

407

Cardiomyopathy (excluding other)

140

278

5.14

66.55

1.3

533.55

715.67

u/l

0.21

133

259

Acute tubulo-interstitial nephritis

476

1776

2.40

66.51

1.3

583.02

486.91

u/l

0.27

447

1696

Conduction disorders

249

608

3.45

66.45

1.4

1.3

257.76

678.86

u/l

5.76

239

580

COPD, early/later onset

485

1737

2.39

66.07

1.3

1.4

646.48

450.79

u/l

0.65

460

1638

Cardiomyopathies, Primary/intrinsic

136

265

5.24

66.06

1.3

539.53

722.82

u/l

0.20

129

249

Covid-19 confirmed case

270

864

3.17

65.98

1.3

472.88

388.55

u/l

0.37

262

812

Implicit viral Sepsis

211

580

3.71

65.68

1.4

1.3

288.49

365.12

u/l

1.00

197

553

Viral Sepsis

211

580

3.71

65.68

1.4

1.3

288.49

365.12

u/l

1.00

197

553

Asthma-related pneumonia

363

1377

2.67

64.74

1.3

690.13

417.66

u/l

0.75

334

1300

Asthma-related pneumonia or sepsis

363

1378

2.66

64.64

1.3

690.13

417.57

u/l

0.75

334

1301

Asthma, hospital admissions 3, pneumonia

363

1378

2.66

64.64

1.3

690.13

417.57

u/l

0.75

334

1301

Codes for special purposes

344

1273

2.73

64.44

1.4

1.3

455.83

503.35

u/l

0.19

333

1201

Provisional assignment of new diseases of uncertain etiology

343

1270

2.73

64.19

1.4

1.3

456.92

503.73

u/l

0.18

332

1198

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

156

351

4.54

63.84

1.4

1.3

362.21

311.18

u/l

0.46

146

332

Neoplasms

404

805

2.70

63.24

1.4

1.3

398.57

536.52

u/l

1.08

383

759

Polyarthropathies

555

1655

2.25

63.08

1.4

1.3

420.86

518.41

u/l

0.81

521

1577

Valvular operations

150

331

4.62

62.87

1.5

1.3

228.67

690.67

u/l

3.37

142

312

Glomerular diseases

216

625

3.53

62.33

1.4

1.3

279.31

334.46

u/l

0.71

203

597

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

228

396

3.67

61.55

1.3

1.2

712.54

813.02

u/l

0.16

216

374

Any reimbursement code in KELA

228

291

3.94

61.54

1.4

1.2

389.66

748.32

u/l

1.47

219

274

Allergic asthma (mode), excluding more controls

9.24

60.96

1.2

685.31

352.03

u/l

0.67

Other CVD (FINNGEN)

116

152

6.12

60.58

1.2

874.73

715.23

u/l

0.13

108

146

Glomerular disorders in diseases classified elsewhere

160

384

4.28

60.44

1.4

1.3

281.92

334.56

u/l

0.48

150

367

COPD, hospital admission 2, with asthma infections

371

1241

2.59

60.12

1.3

663.85

387.36

u/l

0.83

352

1170

Presence of cardiac and vascular implants and grafts

473

1553

2.33

59.83

1.4

1.3

236.52

567.80

u/l

6.05

453

1473

Diabetic nephropathy, excluding more controls

184

397

3.96

59.51

1.3

260.22

467.01

u/l

1.50

170

379

Malaise and fatigue

402

1375

2.46

58.63

1.3

415.69

512.81

u/l

0.48

372

1310

ILD medications: immunosuppressive drugs

401

1604

2.41

58.07

1.4

1.3

463.81

512.14

u/l

0.35

384

1524

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

134

283

4.72

57.63

1.2

1.3

435.44

254.89

u/l

3.67

129

260

Complications of surgical and medical care, not elsewhere classified

689

2511

1.98

57.33

1.4

1.3

379.12

506.56

u/l

0.94

657

2369

Hypertension, essential

482

1189

2.33

56.84

1.4

1.3

375.52

661.32

u/l

3.67

457

1136

All influenza

192

546

3.56

56.70

1.4

1.3

671.13

343.68

u/l

0.46

175

522

Hypertensive heart and/or renal disease

275

727

2.97

56.60

1.3

508.41

615.56

u/l

0.17

257

699

Tramadol

527

1552

2.20

56.13

1.3

387.30

528.02

u/l

1.31

491

1464

COPD, hospital admissions 3, with asthma pneumonia sepsis

332

1089

2.64

55.70

1.3

701.66

390.04

u/l

0.84

315

1027

Infections, IBD-co-morbidities

166

293

4.18

55.64

1.4

1.2

326.50

588.21

u/l

1.39

154

285

COPD related to multimorbidity

424

1543

2.35

55.51

1.3

668.95

391.59

u/l

0.92

402

1457

Opioids

618

1579

2.06

53.58

1.3

388.33

529.18

u/l

1.47

587

1489

Parasetamol

504

1150

2.25

53.34

1.4

1.3

387.64

480.54

u/l

1.11

478

1095

Iron deficiency anaemia

363

1512

2.40

52.16

1.4

1.3

416.35

471.76

u/l

0.15

338

1432

Symptoms and signs involving the circulatory and respiratory systems

595

1440

2.08

51.97

1.3

365.23

549.12

u/l

2.23

562

1364

Non-follicular lymphoma, hilmo, excluding all cancers

109

217

5.15

51.83

1.4

1.3

364.57

290.08

u/l

0.60

206

Pulmonary heart disease, diseases of pulmonary circulation

313

1255

2.53

50.12

1.3

387.86

467.99

u/l

0.54

296

1186

Cardiovascular diseases

224

367

3.34

50.11

1.4

1.2

390.34

883.06

u/l

3.47

212

348

Chronic lower respiratory diseases

771

2255

1.86

50.04

1.3

613.58

458.95

u/l

0.70

732

2133

Secondary hypertension

7.67

49.52

1.3

1.1

245.25

535.63

u/l

3.32

Pacemaker

362

1521

2.35

48.91

1.4

1.3

223.49

476.50

u/l

4.36

346

1427

Non-allergic asthma (mode)

146

5.95

48.85

1.4

1.2

714.73

240.65

u/l

0.89

138

Type 2 diabetes, wide definition

592

1959

1.98

48.52

1.3

323.18

529.35

u/l

3.43

561

1857

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

205

412

3.27

47.35

1.3

393.00

356.73

u/l

0.13

196

378

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

205

412

3.27

47.35

1.3

393.00

356.73

u/l

0.13

196

378

Peripheral artery disease

443

1680

2.15

46.71

1.3

323.48

516.26

u/l

1.87

410

1600

Nutritional anaemias

407

1833

2.18

46.45

1.4

1.3

390.87

463.95

u/l

0.24

379

1739

Dentinal caries

203

673

3.04

46.40

1.4

1.3

978.05

382.30

u/l

0.90

195

642

Hypertensive diseases

455

1195

2.17

45.53

1.4

1.3

370.43

659.63

u/l

3.75

431

1142

Insulin medication

463

1927

2.07

45.22

1.4

1.3

315.05

536.70

u/l

2.72

436

1824

Hypertension

454

1195

2.16

45.16

1.4

1.3

370.51

659.63

u/l

3.75

430

1142

Codeine

564

1564

1.99

45.04

1.3

469.33

526.71

u/l

0.23

532

1477

Other and unspecified iron deficiency

277

1114

2.51

44.09

1.4

1.3

440.57

424.50

u/l

0.03

261

1051

Dental caries

213

748

2.85

43.48

1.4

1.3

939.20

371.82

u/l

0.90

205

711

Autoimmune diseases excluding thyroid diseases, strict definition

668

2023

1.85

43.11

1.4

1.3

423.38

532.47

u/l

0.97

628

1916

Chronic periapical parodontitis

190

637

3.02

43.09

1.4

1.3

692.58

376.48

u/l

0.86

181

609

Hypo-osmolality and hyponatraemia

176

564

3.16

42.96

1.3

536.82

322.56

u/l

0.79

167

532

Autoimmune diseases excluding thyroid diseases

686

2089

1.83

42.94

1.4

1.3

419.49

523.54

u/l

0.95

645

1979

Asthma, hospital admission 2, infections

412

1945

2.10

42.90

1.3

647.92

424.02

u/l

0.68

379

1842

Asthma-related infections

412

1945

2.10

42.90

1.3

647.92

424.02

u/l

0.68

379

1842

ILD, hospital admissions 3, with pneumonia sepsis

102

226

4.63

42.80

1.4

1.3

503.00

302.62

u/l

1.71

214

Benign neoplasms

362

887

2.32

42.57

1.4

1.3

366.20

510.15

u/l

1.24

340

834

Pulmonary embolism

272

1120

2.46

41.25

1.3

420.44

413.24

u/l

0.04

257

1056

Allergic asthma (mode)

124

5.88

41.10

1.2

1.3

685.31

272.93

u/l

0.92

116

Pulmonary heart disease

272

1128

2.44

40.62

1.3

420.44

408.50

u/l

0.07

257

1063

Disorders of lipoprotein metabolism and other lipidaemias

575

1928

1.89

40.58

1.3

398.47

510.23

u/l

0.96

545

1820

ILD, hospital admission 2, with pulmonary infections

107

257

4.26

40.47

1.4

1.3

507.50

329.68

u/l

1.49

247

Complications of procedures, not elsewhere classified

533

2452

1.89

40.33

1.4

1.3

406.23

505.93

u/l

0.51

508

2315

Other diseases of the respiratory system

225

859

2.66

40.11

1.4

1.3

310.01

388.02

u/l

0.74

207

813

Other respiratory disorders and diseases

225

859

2.66

40.11

1.4

1.3

310.01

388.02

u/l

0.74

207

813

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

129

246

3.93

40.02

1.4

1.2

473.21

591.74

u/l

0.34

120

238

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

296

978

2.38

39.90

1.3

519.49

396.81

u/l

0.23

278

911

Diabetic nephropathy

186

637

2.94

39.79

1.3

258.34

476.84

u/l

1.50

172

604

Diseases of pulp and periapical tissues

261

1074

2.45

39.58

1.4

1.3

609.07

417.49

u/l

0.64

250

1019

Secondary uncertain malignant neoplasm

153

478

3.27

39.34

1.4

1.3

363.30

324.18

u/l

0.37

145

453

Calcific aortic valvular stenosis, diagnosis (helper)

319

1406

2.25

39.32

1.4

1.3

343.51

438.40

u/l

0.45

294

1330

Operations 2 for CAVS

319

1406

2.25

39.32

1.4

1.3

343.51

438.40

u/l

0.45

294

1330

Hypertensive Heart Disease

226

698

2.68

39.27

1.3

568.61

593.58

u/l

0.03

212

671

Calcific aortic valvular stenosis

319

1407

2.25

39.25

1.4

1.3

343.51

438.26

u/l

0.45

294

1331

Calcific aortic valvular stenosis, operated

319

1407

2.25

39.25

1.4

1.3

343.51

438.26

u/l

0.45

294

1331

In situ neoplasms

216

774

2.68

39.15

1.3

589.58

322.69

u/l

0.44

208

712

Venous thromboembolism

438

2158

1.99

39.13

1.3

504.45

480.50

u/l

0.11

409

2041

Gout

295

1169

2.33

38.98

1.4

1.3

272.22

570.33

u/l

3.03

279

1106

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

342

1050

2.24

38.98

1.3

478.73

417.58

u/l

0.20

326

976

Calcific aortic valvular stenosis, including rheumatic fever

319

1410

2.24

38.97

1.4

1.3

343.51

439.52

u/l

0.46

294

1334

Atherosclerosis, excluding cerebral and coronary sclerosis

410

1609

2.06

38.86

1.3

313.26

487.41

u/l

1.64

378

1531

DVT of lower extremities and pulmonary embolism

360

1711

2.12

38.41

1.3

466.12

480.03

u/l

0.06

338

1619

Hard cardiovascular diseases

555

1933

1.85

37.39

1.3

330.26

540.81

u/l

3.36

527

1840

Complications of medical and surgical care

495

2519

1.88

37.35

1.4

1.3

382.01

493.86

u/l

0.55

471

2382

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

196

4.59

36.71

1.4

1.3

253.00

280.04

u/l

0.18

185

Insulin, fast-acting

280

1229

2.30

36.68

1.3

236.34

507.58

u/l

3.92

263

1163

Pure hypercholesterolaemia

519

1867

1.88

36.66

1.3

420.11

498.85

u/l

0.52

492

1760

Lung transplant status

26.26

36.48

1.5

1.2

316.42

323.51

u/l

0.01

Lung transplantation

26.25

36.48

1.5

1.2

316.42

323.51

u/l

0.01

Later onset COPD

318

1140

2.22

36.38

1.3

560.69

377.59

u/l

0.83

300

1075

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

318

982

2.24

36.19

1.3

471.04

411.80

u/l

0.18

302

913

Pain in throat and chest

457

1432

1.96

36.01

1.4

1.3

543.35

548.96

u/l

0.01

425

1356

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

150

383

3.20

35.88

1.3

444.11

355.93

u/l

0.27

142

351

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

312

967

2.24

35.77

1.3

477.40

411.96

u/l

0.19

296

899

Gout, FINNGEN

295

1347

2.22

35.35

1.4

1.3

272.22

499.72

u/l

2.68

279

1272

Depression medications

5.78

35.31

1.5

1.3

386.21

712.58

u/l

2.07

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

311

974

2.21

34.56

1.3

478.96

411.86

u/l

0.20

295

906

STROKE

374

1271

2.05

34.54

1.3

346.25

598.03

u/l

2.89

356

1207

Diabetes, varying definitions

609

2072

1.76

34.50

1.3

342.99

540.54

u/l

3.03

582

1961

Coronary atherosclerosis

508

1776

1.86

34.45

1.4

1.3

294.95

557.57

u/l

4.72

482

1679

Insulin, combination of fast acting with intermediate-acting or long-acting

463

2297

1.87

34.43

1.4

1.3

315.05

514.39

u/l

2.60

436

2170

Insulin, intermediate and long-acting

418

2144

1.93

34.32

1.4

1.3

257.78

523.11

u/l

5.80

393

2029

Diabetes mellitus

608

2071

1.76

34.15

1.3

343.62

540.68

u/l

3.01

581

1960

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

591

2056

1.76

33.63

1.3

334.42

541.88

u/l

3.22

563

1946

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

112

318

3.58

33.49

1.3

857.70

291.22

u/l

0.99

107

299

Lymphoid leukaemia

121

5.51

33.44

1.4

1.3

286.16

310.64

u/l

0.17

116

Insulin, fast-acting or short human

282

1292

2.20

33.35

1.3

241.62

496.94

u/l

3.78

265

1222

Cardiomyopathy, other and unspecified

154

4.83

32.52

1.5

1.3

850.99

475.84

u/l

0.24

144

Oedema, not elsewhere classified

233

992

2.36

32.46

1.4

1.3

333.63

522.84

u/l

0.99

219

946

Diseases of oesophagus, stomach and duodenum

655

2357

1.69

32.44

1.4

1.3

548.96

479.58

u/l

0.27

613

2242

Adjustment and management of implanted device

178

674

2.68

32.35

1.4

1.3

223.93

542.58

u/l

1.97

173

632

Other diseases of blood and blood-forming organs, wide

184

710

2.62

32.16

1.3

735.75

342.64

u/l

0.82

175

670

Ulcer of lower limb, not elsewhere classified

154

543

2.89

32.15

1.4

1.3

377.89

329.94

u/l

0.15

145

518

Other disorders of skin and subcutaneous tissue

470

2387

1.81

31.78

1.4

1.3

417.49

484.73

u/l

0.40

436

2270

Diabetes, insulin treatment (Kela reimbursement)

627

2267

1.70

31.38

1.3

347.70

538.79

u/l

2.60

599

2144

Endocrine, nutritional and metabolic diseases

427

1126

1.94

31.22

1.3

362.18

614.36

u/l

2.66

411

1069

Enterocolitis due to Clostridium difficile

117

361

3.30

30.78

1.4

1.3

232.28

296.31

u/l

1.30

103

345

Disorders of lens

479

1674

1.82

30.25

1.3

301.60

496.44

u/l

4.41

452

1589

Type 2 diabetes

590

2054

1.71

30.23

1.3

345.90

541.64

u/l

2.90

564

1944

Enlarged lymph nodes

126

412

3.09

30.00

1.3

1.4

363.79

391.76

u/l

0.19

119

394

Secondary and unspecified malignant neoplasm of lymph nodes

266

3.69

29.89

1.4

1.3

360.48

346.52

u/l

0.07

255

Glucagon-like peptide-1 (GLP-1) analogues

431

1942

1.84

29.86

1.4

1.3

263.10

514.82

u/l

5.07

401

1841

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

173

304

2.86

29.76

1.4

1.2

359.29

387.10

u/l

0.30

164

289

Disorders of choroid and retina

563

2414

1.71

29.68

1.3

402.49

495.57

u/l

0.46

538

2280

Hernia of abdominal wall, postoperative

107

320

3.37

29.48

1.3

316.00

709.79

u/l

1.10

100

306

Gout, idiopatic and unspecified

242

1100

2.23

29.46

1.4

1.3

280.13

526.06

u/l

2.29

230

1045

Antihypertensive medication - note that there are other indications

215

477

2.47

29.00

1.4

1.2

374.23

780.95

u/l

3.37

205

450

Cardiodefibrillation

327

1672

1.97

28.88

1.4

1.3

353.70

527.22

u/l

1.05

311

1589

Streptococcal septicaemia

251

3.70

28.52

1.2

1.3

990.87

335.58

u/l

0.65

238

Explicit bacterial Sepsis

101

299

3.43

28.38

1.2

1.3

902.93

355.54

u/l

0.59

285

Diabetes medication

599

2193

1.67

27.98

1.3

345.65

545.14

u/l

2.91

572

2075

Other bacterial intestinal infections

156

597

2.65

27.81

1.4

1.3

303.34

400.66

u/l

0.68

140

561

Intestinal infectious diseases

551

2568

1.68

27.62

1.3

379.14

513.07

u/l

1.90

513

2434

Type 1 diabetes, wide definition, subgroup 1

139

502

2.79

27.61

1.3

224.41

433.02

u/l

7.50

129

478

Ischemic heart diseases

517

1886

1.73

27.55

1.4

1.3

301.37

556.55

u/l

4.73

490

1781

Fall on same level

656

2259

1.63

27.50

1.3

638.98

468.87

u/l

0.65

616

2142

Other retinal disorders

465

2146

1.75

27.36

1.3

275.24

492.18

u/l

4.87

441

2027

Diarrhoea and gastroenteritis of presumed infectious origin

408

2061

1.81

27.34

1.3

395.91

548.45

u/l

1.66

383

1947

Care involving use of rehabilitation procedures

351

1777

1.88

27.10

1.3

501.20

521.10

u/l

0.05

329

1669

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

145

544

2.71

26.98

1.5

1.3

807.07

343.51

u/l

0.66

135

519

Non-follicular lymphoma

109

350

3.18

26.96

1.4

1.3

364.57

324.49

u/l

0.28

334

Senile cataract

454

1595

1.78

26.64

1.4

1.3

447.85

488.13

u/l

0.10

426

1516

COPD, hospital admissions 1, only main diagnosis

322

1427

1.94

26.45

1.3

583.11

429.66

u/l

0.34

305

1350

Cerebrovascular diseases

530

2272

1.68

26.37

1.3

321.09

515.19

u/l

3.34

501

2157

Cirrhosis of liver, NAS

153

4.44

26.36

1.5

1.4

206.27

343.02

u/l

1.98

148

Myocardial infarction

398

1577

1.82

26.30

1.3

312.35

564.49

u/l

3.50

375

1488

Type 1 diabetes

168

683

2.48

26.28

1.3

234.18

524.97

u/l

3.92

160

646

Malignant neoplasm of ovary

5.39

26.17

1.1

1.3

423.29

283.19

u/l

1.94

Diseases of liver

239

1136

2.12

25.94

1.4

1.3

648.47

481.54

u/l

0.31

223

1078

Ischaemic heart disease, wide definition

508

1878

1.70

25.79

1.4

1.3

301.73

553.74

u/l

4.60

481

1776

Infections of the skin and subcutaneous tissue

332

1765

1.88

25.78

1.4

1.3

571.30

522.15

u/l

0.12

315

1670

Diseases of the digestive system

345

1867

1.86

25.57

1.4

1.3

538.96

475.36

u/l

0.15

323

1766

Iron deficiency anaemia secondary to blood loss (chronic)

139

526

2.68

25.41

1.4

1.3

292.83

328.87

u/l

0.27

128

498

Codeine or tramadol medication

679

2387

1.58

25.27

1.3

452.66

502.79

u/l

0.25

640

2267

Bacterial intestinal infections, IBD co-morbidities

153

609

2.54

25.21

1.4

1.3

302.48

384.99

u/l

0.55

137

576

Peripheral arterial reconstruction

186

811

2.33

25.15

1.3

368.20

408.48

u/l

0.13

170

768

Gout, unspecified

198

887

2.26

25.09

1.4

1.3

278.13

501.76

u/l

1.55

189

843

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

394

2229

1.77

25.04

1.4

1.3

412.87

501.63

u/l

0.31

376

2111

Agranulocytosis

306

3.22

24.68

1.2

1.4

958.23

335.69

u/l

0.67

297

665

2228

1.58

24.55

1.3

407.19

471.58

u/l

0.71

624

2117

Gout, strict definition

181

790

2.33

24.43

1.5

1.3

227.42

522.26

u/l

2.21

170

746

GI-bleeding

271

1384

1.98

24.21

1.4

1.3

606.42

460.52

u/l

0.30

254

1308

Major coronary heart disease event

510

2058

1.66

24.08

1.4

1.3

303.34

511.12

u/l

3.87

479

1952

Hyperlipidaemia, other/unspecified

301

1508

1.90

23.94

1.4

1.3

253.71

493.58

u/l

4.03

283

1431

Type 1 diabetes, wide definition

144

570

2.54

23.91

1.3

231.33

426.00

u/l

6.72

134

538

Other acute lower respiratory infections

348

1841

1.81

23.87

1.3

519.89

464.66

u/l

0.23

324

1741

Injuries to the head

623

2585

1.57

23.65

1.3

499.12

477.20

u/l

0.08

584

2447

Major coronary heart disease event excluding revascularizations

484

2007

1.67

23.64

1.4

1.3

302.43

512.58

u/l

3.79

456

1905

Symptoms and signs involving the urinary system

501

2362

1.65

23.52

1.4

1.3

492.32

483.35

u/l

0.03

469

2237

COPD-related respiratory insufficiency

131

502

2.66

23.48

1.3

775.00

400.41

u/l

0.35

124

474

Asthma/COPD (KELA code 203)

521

2253

1.63

23.45

1.4

1.3

667.51

447.73

u/l

0.72

491

2131

Other diseases of the digestive system

266

1367

1.96

23.36

1.4

1.3

612.54

462.77

u/l

0.30

249

1292

Other CVD

181

805

2.28

23.34

1.3

646.99

372.14

u/l

0.44

170

753

Persons encountering health services in other circumstances, wide

710

2400

1.54

23.32

1.4

1.3

514.13

487.71

u/l

0.10

678

2266

Benign neoplasm: Ascending colon

307

3.14

23.22

1.6

1.3

213.29

335.04

u/l

2.36

287

Autoimmune diseases

638

2091

1.56

22.32

1.4

1.3

467.23

523.79

u/l

0.25

604

1981

Benign neoplasm: Colon, unspecified

154

648

2.39

22.26

1.4

1.3

356.85

335.95

u/l

0.15

140

613

Bronchitis

611

2582

1.56

22.15

1.3

427.27

495.02

u/l

0.66

573

2444

Diabetic retinopathy, excluding more controls

188

464

2.30

21.98

1.3

480.89

447.40

u/l

0.05

181

442

Abnormal findings on examination of blood, without diagnosis

354

1896

1.76

21.82

1.3

391.49

513.49

u/l

1.04

333

1796

Amputation

109

395

2.81

21.79

1.4

1.3

435.17

430.53

u/l

0.01

100

375

Used for control exclusion in common control thyroid runs

603

1949

1.57

21.68

1.4

1.3

470.71

538.59

u/l

0.29

573

1843

Asthma (diagnoses ohter than nonallergic)

493

2634

1.61

21.40

1.4

1.3

610.94

456.72

u/l

0.51

461

2497

Syncope and collapse

293

1408

1.85

21.39

1.3

449.01

508.96

u/l

0.13

273

1341

Glomerulonephritis

290

3.08

20.88

1.4

1.3

281.63

346.78

u/l

0.60

277

Diseases of the skin and subcutaneous tissue

591

1900

1.56

20.74

1.3

369.94

509.36

u/l

1.92

559

1799

Myocardial infarction, strict

359

1513

1.74

20.57

1.3

448.48

570.16

u/l

0.43

339

1428

Other respiratory diseases principally affecting the interstitium

167

759

2.23

20.53

1.4

1.3

429.42

370.86

u/l

0.36

156

717

374

2029

1.70

20.50

1.3

743.07

485.52

u/l

0.86

347

1928

Type 2 diabetes, strict (exclude DM1)

541

2053

1.58

20.49

1.3

353.59

522.99

u/l

2.24

516

1941

Type 2 diabetes, definitions combined

537

2035

1.58

20.42

1.3

355.63

525.04

u/l

2.21

512

1926

Other disorders of kidney and ureter

112

426

2.67

20.40

1.3

282.58

327.06

u/l

0.40

101

406

Substance abuse, excluding more controls

349

1771

1.73

20.31

1.3

869.05

476.43

u/l

1.32

327

1685

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

267

3.13

19.92

1.4

1.3

381.04

296.49

u/l

0.61

254

Early onset COPD

172

806

2.15

19.56

1.3

789.64

448.48

u/l

0.44

165

764

Alcohol use disorder, Swedish definition

357

1962

1.70

19.49

1.3

737.69

489.63

u/l

0.77

331

1867

Benign neoplasm of colon, rectum, anus and anal canal

426

2386

1.62

19.30

1.4

1.3

509.04

467.93

u/l

0.10

401

2260

Disorders of gallbladder, biliary tract and pancreas

588

2501

1.52

19.16

1.4

1.3

475.22

500.76

u/l

0.09

555

2373

381

2062

1.66

19.14

1.3

733.43

505.13

u/l

0.74

354

1958

Gastroduodenal ulcer

224

1164

1.94

19.02

1.3

475.52

454.74

u/l

0.03

210

1107

Pain in limb

445

2011

1.61

18.85

1.4

1.3

406.45

489.41

u/l

0.72

415

1904

Other (not insulin) diabetes medications

551

2165

1.54

18.80

1.3

352.35

529.88

u/l

2.33

524

2049

Use of hypnotics and sedatives

609

2347

1.50

18.58

1.3

557.59

493.47

u/l

0.27

576

2222

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

574

2474

1.52

18.52

1.4

1.3

502.55

487.09

u/l

0.06

543

2341

ILD, hospital admissions

141

625

2.29

18.49

1.4

1.3

484.05

382.72

u/l

0.58

130

589

Benign neoplasm: Sigmoid colon

112

447

2.53

18.48

1.5

1.3

293.92

306.11

u/l

0.11

106

420

Other interstitial pulmonary diseases

142

632

2.28

18.44

1.4

1.3

481.99

379.16

u/l

0.60

131

596

Type 2 diabetes, definitions combined, including avohilmo

529

2032

1.55

18.35

1.3

357.36

538.14

u/l

2.35

503

1922

Malignant neoplasm of breast

234

885

1.92

18.32

1.3

365.91

383.35

u/l

0.07

224

833

Mental and behavioural disorders due to psychoactive substance use

359

2045

1.66

18.28

1.3

857.13

488.48

u/l

1.26

337

1939

Interstitial lung disease endpoints

142

636

2.26

18.17

1.4

1.3

481.99

378.61

u/l

0.61

131

600

Interstitial lung disease

142

636

2.26

18.17

1.4

1.3

481.99

378.61

u/l

0.61

131

600

All influenza (not pneumonia)

261

3.01

18.01

1.4

1.3

279.97

367.66

u/l

1.02

250

Hypotension

151

698

2.19

17.87

1.2

1.3

734.13

373.33

u/l

0.50

142

653

Stroke, including SAH

448

2113

1.58

17.64

1.3

315.21

515.39

u/l

3.16

419

2006

Symptoms and signs involving the digestive system and abdomen

591

1971

1.51

17.63

1.4

1.3

443.92

535.64

u/l

0.50

553

1871

Nausea and vomiting

168

798

2.08

17.61

1.3

279.06

360.00

u/l

1.31

157

750

Substance abuse

349

2021

1.66

17.58

1.3

869.05

491.25

u/l

1.25

327

1916

Malignant neoplasm of breast, HER2-negative

228

885

1.90

17.54

1.3

372.33

382.57

u/l

0.04

218

833

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

351

2135

1.65

17.51

1.4

1.3

423.13

501.01

u/l

0.23

334

2027

Volume depletion

299

2.85

17.45

1.3

289.97

455.10

u/l

0.60

281

Osteopathies and chondropathies

318

1787

1.70

17.43

1.3

325.57

471.38

u/l

2.01

296

1694

Peripheral artery operations in Hilmo

123

528

2.36

17.37

1.4

1.3

446.82

448.41

u/l

0.00

114

502

ILD, hospital admissions 1, main diag only

127

554

2.33

17.34

1.3

488.36

326.67

u/l

1.59

116

523

Unspecified acute lower respiratory infection

108

441

2.47

17.03

1.3

616.42

360.00

u/l

1.04

100

419

L04AX Other immunosuppressants

288

1685

1.72

16.69

1.4

1.3

549.65

475.08

u/l

0.54

277

1603

Drug-induced neutropenia

186

3.33

16.56

1.3

545.78

359.51

u/l

0.97

180

Hydronephrosis

337

2.67

16.44

1.2

1.3

578.10

318.61

u/l

0.83

321

Coronary revascularization (ANGIO or CABG)

346

1468

1.65

16.39

1.4

1.3

342.54

576.02

u/l

2.29

323

1386

Other soft tissue disorders, not elsewhere classified

502

2048

1.52

16.29

1.4

1.3

414.43

505.42

u/l

0.85

468

1938

Reimbursement for rheumatic diseases

318

1920

1.66

16.25

1.3

486.82

489.13

u/l

0.01

303

1816

Open wound of head

324

1940

1.65

16.24

1.3

509.66

490.17

u/l

0.05

305

1839

Alcoholic liver disease

341

2.65

16.09

1.3

1237.67

380.90

u/l

0.74

323

Second line medication for Crohn's disease

291

1725

1.69

16.09

1.4

1.3

546.72

471.31

u/l

0.56

280

1642

Rheumatoid arthritis

217

1074

1.85

15.90

1.4

1.3

580.71

507.55

u/l

0.33

208

1025

Pain, not elsewhere classified

140

658

2.14

15.86

1.3

719.13

388.21

u/l

1.00

133

628

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

170

860

1.99

15.82

1.3

615.58

344.81

u/l

3.29

162

815

Biguanides

540

2249

1.48

15.71

1.3

379.91

519.57

u/l

1.43

510

2131

Cough

207

1073

1.86

15.67

1.4

1.3

344.76

582.91

u/l

2.13

196

1021

Convulsions, not elsewhere classified

129

582

2.20

15.66

1.3

1.4

730.54

504.79

u/l

0.25

119

557

Idiopathic gout

376

2.54

15.62

1.5

1.3

288.09

363.43

u/l

0.50

361

Emphysema

251

2.92

15.61

1.2

1.4

440.24

316.50

u/l

0.89

237

Acute bronchitis

260

1478

1.73

15.56

1.4

1.3

478.29

453.82

u/l

0.08

243

1395

Seropositive rheumatoid arthritis

172

878

1.97

15.49

1.3

611.31

421.30

u/l

1.44

164

825

Benign neoplasm: Colon

361

2241

1.59

15.30

1.4

1.3

370.50

495.12

u/l

1.03

337

2131

Stroke, excluding SAH

426

2068

1.54

15.13

1.3

313.45

515.29

u/l

3.07

396

1969

Misadventures to patients during surgical and medical care

411

2.43

15.13

1.6

1.3

231.72

331.05

u/l

1.94

392

Presence of other functional implants

378

1699

1.58

15.12

1.3

349.82

558.02

u/l

1.06

351

1611

Benign neoplasms

534

2019

1.48

15.09

1.4

1.3

475.86

540.13

u/l

0.20

503

1915

Coronary artery bypass grafting

246

1069

1.77

15.02

1.3

255.84

578.51

u/l

3.47

233

1011

Mental and behavioural disorders due to alcohol, excluding acute intoxication

277

1654

1.68

14.92

1.3

850.96

505.50

u/l

0.88

259

1574

Other disorders of teeth and supporting structures

140

675

2.09

14.90

1.5

1.3

841.40

360.25

u/l

0.99

132

643

Seropositive rheumatoid arthritis, wide

172

896

1.93

14.74

1.3

611.31

345.28

u/l

3.27

164

846

Other/unspecified seropositive rheumatoid arthritis

170

885

1.93

14.60

1.3

615.58

346.83

u/l

3.26

162

836

Polyneuropathies and other disorders of the peripheral nervous system

166

858

1.95

14.60

1.3

289.49

428.66

u/l

1.46

157

812

Factors influencing health status and contact with health services

183

466

1.98

14.51

1.3

367.17

552.25

u/l

1.48

174

440

Persons encountering health services for other counselling and medical advice, not elsewhere classified

595

2368

1.44

14.47

1.4

1.3

556.78

488.38

u/l

0.25

567

2236

Direct fill therapy

319

2.59

14.37

1.5

1.4

446.56

368.35

u/l

0.51

308

Finngen Rheumatological endpoints

507

1959

1.48

14.37

1.3

417.15

551.28

u/l

1.21

477

1851

Ischaemic Stroke, excluding all haemorrhages

409

2029

1.53

14.32

1.3

293.98

517.21

u/l

3.63

379

1933

Fracture of femur

206

1044

1.81

14.29

1.2

1.3

588.28

359.74

u/l

0.45

195

980

Bronchiectasis

247

2.84

14.28

1.6

1.3

464.69

337.53

u/l

0.63

234

Dermatitis

336

2133

1.58

14.20

1.4

1.3

405.84

523.22

u/l

1.00

321

2025

Sub-endpoint used in defining T1D endpoints

187

996

1.86

14.18

1.3

226.62

416.30

u/l

4.04

176

941

Other diseases of intestines

543

2177

1.45

14.14

1.4

1.3

459.45

525.87

u/l

0.40

516

2061

Persons with potential health hazards related to communicable diseases

140

682

2.04

14.13

1.3

708.10

410.78

u/l

0.40

128

656

Intestinal stricture

215

1221

1.77

14.01

1.3

476.85

445.13

u/l

0.08

198

1157

Rheumatoid arthritis, including avohilmo

230

1331

1.74

14.01

1.3

566.27

391.66

u/l

1.72

220

1257

Other cataract

283

1327

1.66

13.97

1.3

596.34

402.33

u/l

0.40

276

1262

Mental and behavioural disorders due to alcohol

307

1865

1.61

13.91

1.3

821.58

484.26

u/l

0.99

288

1772

Malignant neoplasm of skin

435

2195

1.50

13.79

1.3

442.25

483.14

u/l

0.16

420

2068

Colorectal cancer, excluding all cancers (controls excluding all cancers)

158

790

1.95

13.79

1.3

702.44

333.57

u/l

0.43

149

735

Constipation

509

2515

1.45

13.78

1.3

534.55

478.75

u/l

0.23

471

2390

Emergency coronary revascularization (for ACS)

419

2008

1.51

13.53

1.4

1.3

331.01

515.37

u/l

2.24

395

1903

Parodontitis or operation codes

497

2526

1.45

13.52

1.3

546.63

475.25

u/l

0.34

468

2394

Symptoms and signs concerning food and fluid intake

271

2.68

13.49

1.2

1.3

845.56

334.44

u/l

0.73

260

Parodontitis

496

2525

1.45

13.44

1.3

547.68

475.30

u/l

0.35

467

2393

Chronic periodontitis, including avohilmo

493

2524

1.45

13.24

1.3

547.73

475.72

u/l

0.35

464

2392

Other and unspecified dermatitis

273

1681

1.63

13.16

1.4

1.3

365.64

542.51

u/l

1.94

260

1597

Benign neoplasm of other and ill-defined parts of digestive system

388

2.36

13.15

1.3

275.86

309.50

u/l

0.24

362

Diabetic retinopathy

242

895

1.72

13.08

1.3

418.65

388.73

u/l

0.06

231

843

Cellulitis

135

678

2.01

12.93

1.4

1.3

833.66

366.57

u/l

0.74

129

650

Retention of urine

265

1371

1.64

12.83

1.3

460.91

487.24

u/l

0.08

251

1298

Gastric ulcer

141

724

1.96

12.71

1.3

260.97

330.61

u/l

1.29

131

688

Other special examinations and investigations of persons without complaint or reported diagnosis

383

1266

1.54

12.69

1.4

1.3

366.75

510.66

u/l

1.86

362

1200

Injuries to the hip and thigh

305

1777

1.58

12.67

1.3

525.47

448.64

u/l

0.19

290

1675

Myocardial infarction, without ST-elevation

312

1846

1.57

12.61

1.3

414.71

462.32

u/l

0.14

292

1747

Unspecified haematuria

294

1591

1.59

12.52

1.4

1.3

495.35

505.16

u/l

0.02

275

1504

Paralytic ileus and intestinal obstruction

178

991

1.81

12.45

1.3

524.19

489.25

u/l

0.08

165

942

Benign neoplasm: Rectum, anus and anal canal

107

500

2.16

12.44

1.4

1.3

923.22

313.99

u/l

0.50

100

473

Alcohol use disorder, ICD-based

251

1537

1.64

12.42

1.3

847.55

499.04

u/l

0.80

235

1459

212

1231

1.71

12.42

1.3

486.72

420.31

u/l

0.50

197

1158

Hernia

505

2406

1.43

12.37

1.3

495.30

488.08

u/l

0.03

478

2278

Other and unspecified polyneuropathies, also in other diseases

146

768

1.92

12.28

1.4

1.3

278.58

378.92

u/l

1.41

138

727

Abnormalities of heart beat

173

951

1.81

12.23

1.3

241.06

580.83

u/l

3.52

166

901

Basal cell carcinoma

395

2127

1.49

12.22

1.3

446.16

420.49

u/l

0.09

375

2007

Basal cell carcinoma, including avohilmo

400

2141

1.48

12.01

1.3

442.18

419.84

u/l

0.08

380

2021

Intracranial trauma

285

1341

1.59

12.00

1.3

377.66

548.87

u/l

1.87

271

1282

Falls/tendency to fall

565

2018

1.40

11.98

1.3

568.52

461.66

u/l

0.34

530

1914

Gastrointestinal diseases

271

830

1.64

11.84

1.4

1.3

359.51

469.93

u/l

1.58

262

794

General examination and investigation of persons without complaint and reported diagnosis

360

1262

1.52

11.67

1.4

1.3

354.20

511.90

u/l

2.14

340

1196

Other malignant neoplasms of skin (=non-melanoma skin cancer)

385

2067

1.48

11.56

1.4

1.3

435.33

423.10

u/l

0.04

369

1945

Seropositive rheumatoid arthritis, strict definition

424

2.21

11.55

1.4

704.59

347.59

u/l

3.00

402

Viral infections characterized by skin and mucous membrane lesions

209

1247

1.68

11.44

1.3

365.04

426.87

u/l

0.62

198

1178

Medicines for HER+ breast cancer

159

855

1.82

11.43

1.3

431.63

364.27

u/l

0.23

151

805

Symptoms and signs involving cognition, perception, emotional state and behaviour

512

2576

1.40

11.20

1.3

531.87

478.81

u/l

0.19

477

2452

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

208

2.72

10.89

1.6

1.3

188.37

350.09

u/l

4.16

201

Mycoses

155

864

1.80

10.88

1.4

1.3

356.14

369.10

u/l

0.10

145

820

Sequelae of external causes of morbidity and mortality

153

850

1.81

10.87

1.4

1.3

388.09

360.02

u/l

0.11

142

803

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

110

548

2.02

10.86

1.2

1.3

293.03

296.47

u/l

0.03

102

511

Genitourinary diseases

319

1040

1.54

10.85

1.4

1.3

347.06

640.56

u/l

3.75

299

1002

Cutaneous abscess, furuncle and carbuncle

135

725

1.87

10.69

1.3

418.76

382.29

u/l

0.23

129

698

Benign neoplasm of other and unspecified endocrine glands

233

2.59

10.67

1.3

248.20

319.19

u/l

1.01

220

Malignant neoplasm of breast, HER-positive

150

825

1.80

10.49

1.3

444.11

360.43

u/l

0.28

142

780

Obesity related asthma

174

1014

1.72

10.48

1.4

1.3

814.34

393.34

u/l

0.58

163

967

L02BG Aromatase inhibitors

134

723

1.86

10.46

1.3

458.54

364.67

u/l

0.28

128

686

Persons encountering health services in other circumstances

183

1085

1.69

10.31

1.4

1.3

328.02

518.75

u/l

1.79

176

1026

Parodontitis and operation codes

450

2503

1.40

10.26

1.3

566.19

477.59

u/l

0.41

422

2373

Osteoporosis

159

866

1.76

10.24

1.4

1.3

298.65

339.15

u/l

0.41

149

816

Other symptoms and signs involving the digestive system and abdomen

400

2.16

10.21

1.3

380.74

364.02

u/l

0.09

377

Examination and observation for other reasons

309

1242

1.52

10.20

1.3

780.56

514.46

u/l

0.49

293

1179

Benign neoplasm: Rectum

433

2.12

10.20

1.5

1.3

1032.77

307.29

u/l

0.50

410

In situ neoplasms

216

1344

1.62

10.14

1.3

589.58

432.37

u/l

0.22

208

1267

Supplementary factors related to causes of morbidity and mortality classified elsewhere

158

908

1.75

10.03

1.3

694.04

370.86

u/l

0.53

145

862

Other nutritional deficiencies

278

1793

1.52

10.01

1.3

595.70

496.18

u/l

0.24

265

1705

Benzodiazepine use

517

2699

1.37

10.00

1.3

579.03

473.07

u/l

0.45

479

2562

Benign neoplasm: Adrenal gland

135

3.07

9.93

1.3

270.99

279.04

u/l

0.05

129

Melanocytic naevi

102

514

1.99

9.78

1.4

1.3

345.91

338.75

u/l

0.05

485

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

6.99

9.78

1.9

1.0

214.08

354.35

u/l

0.65

Medical observation and evaluation for suspected diseases and conditions

361

1266

1.46

9.72

1.4

1.3

407.98

510.66

u/l

0.99

349

1200

Acute pancreatitis

129

706

1.84

9.69

1.3

882.29

432.05

u/l

0.56

117

669

Malignant melanoma, excluding all cancers (controls excluding all cancers)

422

2.10

9.69

1.4

1.3

411.02

298.96

u/l

0.98

397

Fentanyl

332

2.25

9.63

1.3

324.97

419.71

u/l

0.34

311

Other arthritis (FG)

166

979

1.70

9.62

1.4

1.3

373.57

527.10

u/l

0.90

154

928

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

104

532

1.97

9.59

1.3

297.27

308.46

u/l

0.10

493

Duodenal ulcer

466

2.04

9.51

1.3

763.81

330.29

u/l

0.41

445

Type of accident

146

834

1.76

9.50

1.3

728.73

369.57

u/l

0.55

135

793

Other external causes of accidental injury

440

1573

1.40

9.44

1.3

436.43

462.51

u/l

0.10

415

1487

Angina pectoris

361

1698

1.44

9.43

1.4

1.3

317.45

550.30

u/l

3.54

339

1604

Clear cell adenocarcinoma of kidney

156

2.87

9.43

1.2

1.4

338.65

345.57

u/l

0.03

151

Erosion of teeth

8.72

9.37

1.8

1.1

362.25

430.86

u/l

0.17

Fracture of rib(s), sternum and thoracic spine

187

1150

1.63

9.27

1.3

644.94

404.64

u/l

0.86

178

1085

Disorders of thyroid, IBD co-morbidities

287

2.14

9.22

1.3

1.2

388.82

591.92

u/l

0.74

278

Benign neoplasm: Stomach

180

2.69

9.21

1.3

215.21

267.80

u/l

0.57

171

Asthma, including avohilmo

595

2613

1.33

9.17

1.4

1.3

629.35

460.28

u/l

0.68

560

2474

Injuries to the abdomen, lower back, lumbar spine and pelvis

217

1377

1.57

9.15

1.4

1.3

775.21

434.15

u/l

0.76

206

1300

Persons encountering health services for specific procedures, not carried out

131

3.00

9.15

1.3

1.2

2135.23

315.98

u/l

0.79

125

Other specified/unspecified arthritis

148

859

1.73

9.12

1.4

1.3

384.15

516.10

u/l

0.69

136

823

Autoimmune diseases related-to ILD

412

2617

1.39

9.12

1.3

548.42

486.60

u/l

0.18

383

2485

Other gastritis (incl. Duodenitis)

143

823

1.75

9.10

1.5

1.3

277.49

360.19

u/l

1.61

124

785

Substance use, excluding alcohol

433

2.04

9.06

1.2

1.3

1678.30

390.58

u/l

1.31

419

Diagnoses used for exclusion with ILD

166

997

1.67

9.04

1.5

1.3

297.21

389.14

u/l

0.98

156

940

Accidents

437

1573

1.39

9.04

1.3

337.83

462.51

u/l

2.31

413

1487

Diabetic retinopathy, strict definition

121

580

1.85

9.03

1.3

206.09

427.58

u/l

3.04

114

549

Statin medication

322

1237

1.46

8.87

1.3

327.43

627.38

u/l

3.47

309

1169

Persons encountering health services for examination and investigation

362

1266

1.44

8.86

1.3

363.33

510.66

u/l

1.95

346

1200

Aortic aneurysm

180

1092

1.63

8.81

1.3

355.55

532.13

u/l

1.26

170

1042

Other or unspecified ileus, impaction or obstruction

127

714

1.79

8.77

1.3

370.36

383.82

u/l

0.07

116

676

Benign neoplasm: Ascending colon

488

1.97

8.74

1.6

1.3

213.29

344.87

u/l

3.64

465

Degeneration of macula and posterior pole

319

1832

1.44

8.68

1.3

289.64

456.86

u/l

2.64

301

1725

Fracture of lumbar spine and pelvis

139

805

1.74

8.64

1.3

746.61

360.16

u/l

0.56

130

757

Open wound of lower leg

390

2.06

8.49

1.3

391.67

345.70

u/l

0.22

377

Congenital malformations, deformations and chromosomal abnormalities

224

1408

1.53

8.36

1.4

1.3

486.42

474.72

u/l

0.03

217

1333

Zoster [herpes zoster]

111

611

1.83

8.26

1.3

281.50

314.88

u/l

0.44

106

580

Injuries to the thorax

260

1771

1.47

8.17

1.3

555.13

537.34

u/l

0.05

249

1673

Sleep disorders (combined)

499

2466

1.33

8.07

1.4

1.3

523.91

500.86

u/l

0.06

466

2344

External causes of morbidity and mortality

337

1185

1.43

8.03

1.4

1.3

344.92

454.65

u/l

1.57

322

1116

Phlebitis and thrombophlebitis (not including DVT)

128

742

1.73

8.00

1.3

537.54

392.34

u/l

0.42

116

697

Parodontitis or/and operation codes

296

1216

1.45

7.96

1.3

599.23

484.77

u/l

0.39

276

1157

Decubitus ulcer and pressure area

213

2.43

7.93

1.3

521.00

303.53

u/l

0.55

206

Disorders of other endocrine glands

201

1285

1.54

7.92

1.3

295.84

376.75

u/l

1.61

184

1214

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

506

1.88

7.83

1.3

539.02

379.49

u/l

1.35

492

Other symptoms and signs involving the urinary system

376

2.04

7.81

1.5

1.3

311.09

348.77

u/l

0.30

359

Injury, poisoning and certain other consequences of external causes

278

948

1.47

7.81

1.4

1.3

328.99

419.33

u/l

1.25

266

894

Diverticular disease of intestine

410

2008

1.36

7.75

1.3

344.45

511.16

u/l

2.28

388

1902

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

6.74

7.62

1.1

157.92

241.11

u/l

0.52

Sequelae with surgical and medical care as external cause

119

687

1.74

7.58

1.4

1.3

408.62

343.77

u/l

0.22

113

652

Corns and callosities

187

2.49

7.58

1.3

317.36

335.01

u/l

0.10

179

Acute pancreatitis (for exclusion)

129

762

1.70

7.57

1.3

882.29

406.94

u/l

0.60

117

727

Poisoning by drugs, medicaments and biological substances

477

1.89

7.56

1.3

584.48

386.50

u/l

1.56

461

Asthma, hospital admissions , main diagnosis only

392

2599

1.35

7.54

1.4

1.3

423.29

498.53

u/l

0.54

361

2467

Thyrotoxicosis with toxic multinodular goitre

164

2.59

7.53

1.5

1.3

412.79

295.64

u/l

0.36

157

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.62

7.47

1.5

1.4

341.25

343.59

u/l

0.00

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

184

714

1.58

7.43

1.4

1.3

525.33

461.32

u/l

0.14

171

672

Other antidepressants

557

2242

1.30

7.38

1.4

1.3

567.31

454.45

u/l

0.52

522

2129

Arterial embolism and thrombosis

202

2.40

7.35

1.3

225.83

349.57

u/l

1.72

195

Fitting and adjustment of other devices

202

1243

1.52

7.33

1.4

1.3

324.42

494.27

u/l

1.53

196

1165

Concussion

226

1321

1.48

7.32

1.3

393.14

552.07

u/l

1.51

212

1265

Neurological diseases, wide definition

116

324

1.80

7.27

1.4

1.2

367.89

587.23

u/l

1.16

110

313

Lung diseases due to external agents

105

593

1.78

7.25

1.4

1.3

323.87

385.83

u/l

0.33

561

Familial hypercholesterolemia

107

608

1.77

7.24

1.4

1.3

295.86

507.18

u/l

0.99

101

570

Respiratory tuberculosis

223

2.32

7.19

1.3

473.47

335.61

u/l

0.88

212

Respiratory tuberculosis, confirmed and not-confirmed

223

2.32

7.19

1.3

473.47

335.61

u/l

0.88

212

Tuberculosis, IBD comorbidity

295

2.12

7.12

1.4

1.3

434.47

299.36

u/l

1.14

283

Other and unspecified local infections of skin and subcutaneous tissue

256

2.21

7.09

1.4

1.3

363.06

317.72

u/l

0.24

245

Abdominal and pelvic pain

511

1971

1.31

7.03

1.4

1.3

482.18

535.64

u/l

0.22

481

1871

Other local infections of skin and subcutaneous tissue

277

2.15

7.00

1.4

1.3

360.17

320.87

u/l

0.21

266

Tuberculosis

265

2.18

6.95

1.3

442.32

318.64

u/l

0.88

253

Exposure to unspecified factor

459

2725

1.31

6.95

1.3

533.29

483.93

u/l

0.16

439

2573

Cholelithiasis, broad definition with cholecystitis

456

2384

1.31

6.93

1.3

497.01

497.26

u/l

0.00

426

2260

Thyrotoxicosis

110

639

1.73

6.89

1.3

315.57

365.92

u/l

0.31

103

604

Obesity and other hyperalimentation

250

1735

1.43

6.81

1.4

1.3

447.53

523.73

u/l

0.53

235

1654

Obesity

249

1731

1.43

6.75

1.3

448.65

524.43

u/l

0.53

234

1650

Systemic connective tissue disorders

181

1195

1.52

6.74

1.3

490.33

401.78

u/l

0.34

170

1127

Coronary angioplasty

250

1343

1.44

6.69

1.3

375.66

584.27

u/l

1.47

234

1268

Disorder of lipoprotein metabolism, unspecified

506

1.81

6.66

1.2

1.3

431.79

340.83

u/l

0.52

477

Diseases of pulp and periapical tissues, including avohilmo

558

2269

1.28

6.66

1.3

423.96

465.29

u/l

0.28

535

2140

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

180

702

1.54

6.62

1.4

1.3

536.96

459.12

u/l

0.17

168

660

Dental pulpitis 1

558

2272

1.28

6.60

1.3

425.75

465.38

u/l

0.26

535

2143

Dental operations

403

1552

1.34

6.56

1.4

1.3

301.46

470.66

u/l

2.40

382

1463

Dental pulpitis 4

556

2272

1.27

6.40

1.3

423.30

465.21

u/l

0.28

533

2144

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

342

1.97

6.37

1.4

1.3

422.57

309.71

u/l

0.78

324

Tuberculosis, wide

309

2.03

6.34

1.4

1.3

434.47

431.04

u/l

0.01

297

Diseases of the eye and adnexa

354

1311

1.35

6.32

1.4

1.3

355.66

525.77

u/l

3.30

336

1245

Intracranial injury

288

2028

1.38

6.29

1.3

339.43

487.18

u/l

2.01

272

1918

210

1284

1.46

6.23

1.3

298.68

450.59

u/l

1.43

195

1206

Benign neoplasm: Skin of other and unspecified parts of face

231

2.18

6.21

1.2

1.3

304.77

271.01

u/l

0.25

219

Sleep apnoea

461

2430

1.29

6.15

1.4

1.3

528.48

504.27

u/l

0.06

432

2309

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

245

2.14

6.15

1.3

306.60

279.02

u/l

0.17

230

Poisoning by medicine

410

1.86

6.13

1.2

1.3

596.56

392.14

u/l

1.36

395

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

252

2.12

6.13

1.2

1.3

303.57

273.65

u/l

0.20

237

Noninfective enteritis and colitis

209

1449

1.44

6.09

1.3

410.26

440.66

u/l

0.12

193

1376

Other infectious diseases

254

2.11

6.03

1.5

1.3

329.80

334.62

u/l

0.02

245

Psychiatric diseases

553

2194

1.26

6.00

1.3

637.84

445.34

u/l

0.95

522

2090

Unspecified jaundice

159

2.42

5.97

1.1

1.3

679.95

324.08

u/l

0.36

151

Sulfonylureas

259

1490

1.39

5.95

1.4

1.3

248.36

473.62

u/l

3.68

241

1415

Delirium, not induced by alcohol and other psychoactive substances

474

1.78

5.89

1.2

1.4

732.50

387.20

u/l

0.49

446

N06DA Anticholinesterases

110

1431

0.62

5.87

1.2

1.3

372.77

406.75

u/l

0.20

1348

Use of anticholinesterases

110

1431

0.62

5.87

1.2

1.3

372.77

406.75

u/l

0.20

1348

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

271

2.04

5.80

1.2

1.3

718.31

395.20

u/l

1.83

261

Thyrotoxicosis, other and/or unspecified

484

1.76

5.78

1.4

245.29

395.57

u/l

2.24

458

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

141

914

1.55

5.78

1.3

326.53

377.94

u/l

0.44

134

870

Missing teeth due to accident, extraction or parodontitis

364

1.88

5.68

1.6

1.4

517.14

358.97

u/l

0.68

349

Cholecystitis

533

1.72

5.63

1.3

1041.94

401.18

u/l

0.58

504

Sequelae of cerebrovascular disease

233

1467

1.40

5.62

1.4

1.3

320.38

487.98

u/l

1.56

219

1394

Unspecified fall

242

1740

1.38

5.56

1.3

777.02

468.59

u/l

0.62

232

1649

Other viral diseases

103

624

1.65

5.54

1.3

441.41

394.09

u/l

0.25

601

Leiomyoma of uterus

104

347

1.69

5.54

1.3

1.2

305.34

384.86

u/l

0.49

321

Chronic myeloid leukaemia [CML], BCR/ABL-positive

4.95

5.54

1.5

1.3

377.08

264.91

u/l

0.26

Obesity due to excess calories

178

1223

1.46

5.53

1.4

1.3

450.50

506.08

u/l

0.29

167

1165

Suicide or other Intentional self-harm

545

1.69

5.46

1.3

552.35

385.01

u/l

1.40

520

Any mental disorder

564

2271

1.25

5.44

1.3

677.76

439.92

u/l

1.26

533

2163

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

320

1.92

5.42

1.3

1364.02

274.34

u/l

0.50

302

Weight loss

300

1.95

5.39

1.2

1.4

832.90

348.40

u/l

0.50

290

Neuroendocrine tumor and carcinoma of lung

5.74

5.36

1.3

1.4

412.32

214.59

u/l

—

Soft tissue disorders

500

2065

1.26

5.36

1.4

1.3

393.11

503.74

u/l

0.88

469

1953

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

571

1.67

5.35

1.3

539.02

390.79

u/l

1.22

545

Benign neoplasm: Colon, unspecified

154

1037

1.49

5.34

1.4

1.3

356.86

428.04

u/l

0.54

140

982

Benign neoplasm: Sigmoid colon

112

704

1.60

5.31

1.5

1.3

293.92

339.08

u/l

0.56

106

667

Diseases of oral cavity, salivary glands and jaws

479

1947

1.26

5.29

1.3

348.58

426.39

u/l

1.33

453

1833

Secondary thrombocytopenia

5.11

5.29

1.1

1.3

816.44

258.85

u/l

0.78

Retinal vascular disorders

484

1.73

5.26

1.3

256.76

330.53

u/l

0.99

454

Other condition

331

1.88

5.24

1.2

1.4

440.21

356.35

u/l

0.54

321

Pain (limb, back, neck, head abdominally)

397

1541

1.29

5.22

1.4

1.3

446.12

549.28

u/l

0.41

375

1464

DVT of lower extremities

113

715

1.59

5.21

1.3

612.45

404.70

u/l

0.53

104

667

Dental caries 3

460

1858

1.27

5.20

1.4

1.3

346.76

428.38

u/l

1.30

432

1753

Conductive and sensorineural hearing loss

437

2392

1.27

5.20

1.3

368.71

506.79

u/l

1.63

415

2261

Gastro-oesophageal reflux disease

325

2201

1.31

5.19

1.4

1.3

672.59

487.44

u/l

0.45

305

2102

Gingivitis and periodontal diseases

468

1916

1.26

5.15

1.3

471.44

426.63

u/l

0.26

447

1806

Obesity, other/unspecified

125

811

1.55

5.15

1.4

1.3

506.75

371.33

u/l

1.15

117

774

Benign neoplasm: Caecum

236

2.05

5.15

1.4

1.3

249.85

288.07

u/l

0.33

220

Alcohol dependence

149

1005

1.49

5.13

1.3

1070.30

519.53

u/l

0.79

139

958

Dermatitis and eczema

511

2699

1.24

5.11

1.4

1.3

390.95

508.73

u/l

1.49

485

2550

Acute upper respiratory infections of multiple and unspecified sites

317

1809

1.31

5.09

1.3

445.00

556.23

u/l

0.80

302

1708

Exclusions for E4_PCOS_CONSORTIUM

237

1082

1.37

4.97

1.3

509.66

405.44

u/l

0.40

221

1027

Other noninfective gastroenteritis and colitis

114

731

1.56

4.96

1.2

1.3

493.51

347.34

u/l

0.39

101

694

Dental caries 3 and operation codes

489

2010

1.25

4.95

1.4

1.3

395.10

457.95

u/l

0.42

462

1900

Retinal vascular occlusion

478

1.71

4.95

1.3

258.64

331.10

u/l

0.95

448

Cholelithiasis

424

2358

1.26

4.94

1.3

387.56

496.27

u/l

0.65

396

2237

Other functional intestinal disorders

228

1591

1.37

4.93

1.3

612.08

477.31

u/l

0.35

209

1509

Small cell lung cancer

100

2.65

4.92

1.2

1.3

483.78

307.75

u/l

0.56

Small cell lung cancer, helper endpoint

100

2.65

4.92

1.2

1.3

483.78

307.75

u/l

0.56

Chronic diseases of tonsils and adenoids

179

1598

0.71

4.89

1.3

503.36

528.99

u/l

0.10

169

1528

Sensorineural hearing loss

424

2357

1.26

4.89

1.3

374.53

505.49

u/l

1.45

402

2228

Other disorders of ear

465

2487

1.25

4.85

1.3

374.34

510.67

u/l

1.70

442

2353

Other neurological diseases

394

2507

1.27

4.79

1.4

1.3

315.77

496.12

u/l

2.75

370

2373

Diaphragmatic hernia

195

1404

1.39

4.75

1.4

1.3

467.29

462.37

u/l

0.02

186

1332

Superficial injury of head

105

669

1.57

4.73

1.3

826.84

377.95

u/l

0.49

638

Schizophrenia or delusion, excluding more controls

114

734

1.54

4.73

1.3

547.77

363.89

u/l

2.18

107

702

147

952

1.47

4.72

1.3

281.77

417.27

u/l

1.32

134

895

Fracture of lower leg, including ankle

249

1857

1.34

4.72

1.3

755.46

493.05

u/l

0.45

232

1769

Sleep apnoea, including avohilmo

469

2454

1.24

4.69

1.4

1.3

530.14

502.88

u/l

0.07

440

2333

Disorders of parathyroid gland

110

701

1.56

4.69

1.4

1.3

245.60

356.02

u/l

1.75

101

658

Other reaction to severe stress, and adjustment disorders

108

694

1.56

4.68

1.4

1.3

371.92

408.64

u/l

0.31

100

661

Benign neoplasm of mouth and pharynx

211

2.05

4.66

1.2

1.3

259.22

280.37

u/l

0.15

201

Dental caries 1

441

1799

1.26

4.65

1.4

1.3

337.00

431.78

u/l

1.59

415

1693

Explicit fungal Sepsis

4.94

4.58

1.8

1.7

343.40

232.25

u/l

—

Actinic keratosis

246

1757

1.33

4.53

1.3

386.62

435.18

u/l

0.22

233

1655

Unstable angina pectoris

247

1538

1.34

4.51

1.4

1.3

321.14

530.77

u/l

2.44

226

1463

260

1857

1.32

4.49

1.3

378.65

429.44

u/l

0.25

246

1751

Dental caries, including avohilmo

439

1800

1.25

4.45

1.4

1.3

337.62

431.78

u/l

1.58

413

1693

Dental caries 1 and operation codes

473

1964

1.24

4.42

1.4

1.3

393.70

457.94

u/l

0.41

448

1853

Diseases of the musculoskeletal system and connective tissue

242

902

1.35

4.36

1.4

1.3

383.51

595.92

u/l

1.55

230

864

Infections with a predominantly sexual mode of transmission

479

1.65

4.36

1.2

1.3

407.95

403.00

u/l

0.03

455

Skin changes due to chronic exposure to nonionizing radiation

249

1788

1.32

4.33

1.3

386.16

432.98

u/l

0.22

236

1686

Dental pulpitis 2

397

1621

1.26

4.26

1.3

335.00

414.25

u/l

1.16

376

1523

Fracture of foot, except ankle

585

1.58

4.23

1.3

424.35

391.69

u/l

0.21

562

Retinal detachments and breaks

197

1453

1.36

4.20

1.3

512.41

523.11

u/l

0.02

190

1375

Idiopathic pulmonary fibrosis

329

1.78

4.15

1.5

1.3

451.32

322.00

u/l

1.08

313

Leisure time condition

510

1.61

4.15

1.4

933.71

328.87

u/l

0.52

489

Any prescribed medicine buy

+∞

4.13

1.6

0.0

158.20

—

u/l

—

Symptoms and signs involving the skin and subcutaneous tissue

309

2421

1.27

4.10

1.3

448.73

495.81

u/l

0.25

289

2302

Abnormal weight loss

279

1.84

4.09

1.3

1.4

354.66

357.77

u/l

0.01

269

Fracture of shoulder and upper arm

168

1213

1.39

4.08

1.3

607.78

402.12

u/l

0.33

160

1146

Exclusions for E4_PCOS_BROAD

413

1.68

4.05

1.2

1.3

355.76

362.51

u/l

0.04

397

Pneumonitis due to solids and liquids

317

1.78

4.03

1.5

1.4

265.75

317.62

u/l

0.58

301

Neurological diseases

404

1637

1.24

4.01

1.3

360.08

514.87

u/l

2.43

377

1560

Injuries to the ankle and foot

246

1721

1.30

3.93

1.3

531.50

543.77

u/l

0.04

225

1644

Hyperparathyroidism

605

1.54

3.92

1.4

1.3

199.77

331.53

u/l

3.99

566

Abdominal aortic aneurysm (AAA)

522

1.59

3.91

1.2

1.3

408.94

433.34

u/l

0.08

498

Osteonecrosis

151

2.14

3.90

1.3

526.44

339.92

u/l

0.80

145

Arthropathies

411

1693

1.24

3.90

1.4

1.3

454.80

538.39

u/l

0.33

385

1611

Selective deficiency of immunoglobulin G [IgG] subclasses

7.47

3.89

1.6

1.4

477.00

285.43

u/l

—

Right hemicolectomy

213

1.94

3.87

1.2

1.3

247.47

330.32

u/l

0.97

207

Dizziness and giddiness

366

2396

1.24

3.87

1.3

371.68

470.86

u/l

1.12

340

2281

Dermatophytosis

451

1.63

3.83

1.4

1.3

391.39

344.97

u/l

0.24

433

Injuries to the elbow and forearm

286

2032

1.27

3.82

1.2

1.3

631.32

487.12

u/l

0.32

265

1930

Inguinal hernia

326

1748

1.26

3.81

1.3

545.98

522.74

u/l

0.06

312

1654

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

207

1.94

3.81

1.5

1.3

330.25

348.44

u/l

0.09

201

Transient ischemic attack

305

2011

1.26

3.69

1.3

290.80

497.63

u/l

2.61

289

1915

Schizophrenia, schizotypal and delusional disorders

115

792

1.46

3.68

1.3

545.71

369.46

u/l

2.08

108

754

Osteoporosis with pathological fracture (FG)

189

1.97

3.68

1.2

1.3

227.41

299.41

u/l

0.51

174

Unspecific neurodegenerative disorder

166

1548

0.74

3.67

1.2

1.3

367.69

449.72

u/l

0.59

152

1461

Chronic gastritis

156

1138

1.38

3.63

1.3

617.94

428.84

u/l

0.27

147

1085

Dental pulpitis 2, only avohilmo

401

1672

1.23

3.62

1.4

1.3

318.85

431.15

u/l

2.00

379

1574

Other skin changes

601

1.52

3.61

1.3

538.92

333.27

u/l

0.48

569

Benign neoplasm of other and ill-defined parts of digestive system

601

1.52

3.61

1.3

275.86

336.03

u/l

0.52

569

Exposure to other specified factors

297

2219

1.26

3.60

1.3

726.13

496.89

u/l

0.60

286

2108

Other systemic involvement of connective tissue (FG)

122

850

1.43

3.56

1.3

554.77

425.64

u/l

0.34

114

797

Schizophrenia or delusion

114

790

1.45

3.55

1.3

547.77

372.09

u/l

2.04

107

752

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

5.42

3.53

1.1

1.2

388.30

233.45

u/l

—

Ulcer of oesophagus

258

1.80

3.47

1.3

284.29

347.57

u/l

0.50

247

Benign neoplasm: Adrenal gland

222

1.86

3.46

1.3

1.4

270.99

324.82

u/l

0.48

215

Cardiomyopathies, Secondary/extrinsic

7.18

3.39

1.4

1.9

241.14

428.80

u/l

—

Other disorders of veins

167

1248

1.34

3.34

1.3

491.39

424.42

u/l

0.29

160

1177

Use of antiglaucoma preparations and miotics

306

1.71

3.34

1.3

1.4

783.05

292.34

u/l

0.49

291

Benign neoplasm: Connective and other soft tissue of thorax

8.85

3.29

1.0

1.1

338.67

266.14

u/l

—

Dorsalgia

466

2113

1.20

3.26

1.3

410.73

495.23

u/l

0.69

440

2006

Restrictive cardiomyopathy

5.63

3.25

1.3

140.75

175.67

u/l

—

Malignant neoplasm of digestive organs

235

1820

1.27

3.24

1.3

585.89

437.78

u/l

0.22

219

1723

Contact with and exposure to communicable diseases

454

1.56

3.22

1.4

1.3

302.63

430.15

u/l

1.93

437

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

6.48

3.20

1.4

1.0

238.29

320.00

u/l

—

Dental caries 2 and operation codes, only avohilmo

176

1433

0.76

3.15

1.3

600.49

503.46

u/l

0.30

167

1358

Phobic anxiety disorders

144

2.02

3.14

1.3

1348.77

343.91

u/l

0.62

137

Umbilical hernia

127

921

1.38

3.12

1.2

1.3

389.46

584.11

u/l

1.10

117

879

Noninfectious colitis NAS

358

1.63

3.12

1.3

1.4

230.64

332.85

u/l

1.41

344

Other systemic involvement of connective tissue

125

905

1.39

3.10

1.3

548.29

399.69

u/l

0.43

117

851

Disorders of continuity of bone

194

1.86

3.10

1.4

368.73

355.76

u/l

0.04

188

Other diseases of anus and rectum

150

1117

1.35

3.10

1.4

1.3

592.11

478.03

u/l

0.21

142

1062

Procreative management

474

1.50

3.10

1.3

339.82

402.62

u/l

0.61

456

Fluid overload

7.89

3.10

1.5

1.3

93.17

173.70

u/l

—

Palmar fascial fibromatosis [Dupuytren]

105

739

1.43

3.08

1.4

1.3

296.73

566.19

u/l

1.70

100

700

Sequelae of injuries, of poisoning and of other consequences of external causes

664

1.45

3.08

1.3

464.55

376.18

u/l

0.39

637

Benign neoplasm of other and unspecified endocrine glands

375

1.61

3.08

1.3

1.4

248.20

330.84

u/l

1.37

362

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

5.95

3.04

1.1

1.2

363.43

179.47

u/l

—

Carcinoma in situ of other and unspecified genital organs

5.89

3.03

1.6

1.0

463.27

307.50

u/l

—

Hypothyroidism, strict autoimmune

321

1738

1.22

3.00

1.3

484.80

521.76

u/l

0.09

304

1648

Injury of nerves and spinal cord at thorax level

10.23

2.99

1.0

1.2

856.00

214.80

u/l

—

Alzheimer disease, including avohilmo

142

1370

0.75

2.99

1.2

1.3

406.21

409.64

u/l

0.02

127

1291

Cachexia

4.87

2.95

1.9

1.3

100.38

287.72

u/l

—

Nosocomial condition (hospital)

4.85

2.95

1.8

1.3

394.41

243.55

u/l

—

Dental operations, only avohilmo

402

1718

1.20

2.95

1.4

1.3

316.67

469.74

u/l

2.14

379

1622

Coeliac disease

295

1.67

2.92

1.3

1.4

246.41

343.37

u/l

1.22

285

Dementia in Alzheimer disease

802

0.65

2.91

1.3

304.11

366.46

u/l

0.40

759

Congenital malformations of trachea and bronchus

4.18

2.90

1.3

193.89

280.33

u/l

—

Henoch-Schönlein purpura nephritis (HSPN)

6.92

2.90

1.3

118.17

203.07

u/l

—

Hernia of abdominal wall

219

1737

1.26

2.88

1.3

361.52

548.82

u/l

2.04

204

1652

Melanoma of uvea

5.47

2.88

1.7

1.1

179.14

345.28

u/l

—

Coxarthrosis [arthrosis of hip](FG)

292

1724

1.23

2.85

1.4

1.3

331.26

536.20

u/l

1.93

277

1628

Other and unspecified drugs and medicaments

208

1.79

2.82

1.4

1.3

281.68

348.31

u/l

0.60

202

Erectile dysfunction, exclusion

8.60

2.77

2.0

1.7

208.80

133.67

u/l

—

Perforation of oesophagus

5.16

2.75

1.0

1.4

444.57

236.38

u/l

—

Chronic myeloid leukaemia

6.20

2.72

1.7

1.6

175.00

170.00

u/l

—

Functional dyspepsia

105

757

1.39

2.72

1.3

371.80

385.35

u/l

0.09

726

Injuries to the knee and lower leg

534

2637

1.16

2.71

1.3

571.40

475.92

u/l

0.31

497

2505

Other symptoms and signs involving cognitive functions and awareness

243

1843

1.24

2.70

1.3

465.26

463.07

u/l

0.01

220

1753

Other anxiety disorders

118

768

1.36

2.70

1.3

529.24

376.15

u/l

1.31

110

733

Fibroblastic disorders

133

998

1.34

2.69

1.4

1.3

328.06

529.86

u/l

1.43

126

946

Spondylopathies

401

2057

1.19

2.68

1.3

575.10

480.17

u/l

0.31

375

1954

Dental caries 1, only avohilmo

436

1893

1.18

2.66

1.4

1.3

342.55

423.82

u/l

1.32

409

1784

Diseases of external ear

150

1147

1.31

2.66

1.4

1.3

813.31

466.15

u/l

0.50

137

1082

Disorders of eyelid, lacrimal system and orbit

397

2639

1.18

2.65

1.3

317.32

503.71

u/l

3.84

375

2496

Acute sinusitis

179

1306

1.28

2.63

1.4

1.3

594.83

491.61

u/l

0.28

165

1235

Colectomy operation

638

1.42

2.60

1.2

1.3

273.32

338.42

u/l

0.84

608

Symptoms and signs involving the nervous and musculoskeletal systems

257

2102

1.22

2.59

1.3

546.80

492.25

u/l

0.11

244

1993

Hydrocele

564

1.44

2.58

1.3

991.67

594.11

u/l

0.32

543

Other hearing loss

164

1254

1.29

2.57

1.3

435.18

479.87

u/l

0.15

156

1181

Complications of internal orthopaedic prosthetic devices, implants and grafts

115

852

1.35

2.55

1.4

1.3

272.31

447.03

u/l

1.90

109

807

Previous suicide attempt

5.52

2.55

1.8

1.3

285.00

231.36

u/l

—

Macular pucker

574

1.44

2.55

1.3

298.63

369.26

u/l

0.83

539

Alzheimer disease

124

1239

0.75

2.54

1.3

407.27

397.35

u/l

0.05

109

1170

Alzheimer’s disease, wide definition

1062

0.72

2.50

1.3

365.12

351.38

u/l

0.08

1008

Dental caries 3, only avohilmo

446

1952

1.17

2.50

1.4

1.3

344.87

457.17

u/l

1.51

418

1844

Unspecified protein-energy malnutrition

4.50

2.50

1.1

1.3

98.17

223.04

u/l

—

Fracture of forearm

213

1606

1.24

2.49

1.2

1.3

515.69

423.13

u/l

0.27

196

1528

Malignant neoplasm of renal pelvis

3.93

2.49

1.6

1.2

198.50

206.01

u/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.83

2.47

1.2

1.4

827.55

312.80

u/l

0.69

Fall on and from stairs and steps

109

807

1.35

2.44

1.4

1.3

1337.58

362.65

u/l

0.72

101

770

Benign neoplasm: Connective and other soft tissue of thorax

5.15

2.42

1.0

1.3

338.67

230.97

u/l

—

Shoulder lesions

377

1961

1.18

2.40

1.3

370.34

492.99

u/l

1.57

356

1858

Anxiety (asthma-related co-morbidities)

169

1047

1.27

2.39

1.3

711.93

405.64

u/l

1.13

159

1003

Benign neoplasm: Stomach

305

1.58

2.38

1.3

1.4

215.21

305.17

u/l

1.34

298

Visual disturbances and blindness

221

1802

1.23

2.34

1.3

287.61

510.13

u/l

3.61

209

1704

Disorders of the thyroid gland

435

2451

1.16

2.33

1.3

445.53

491.06

u/l

0.16

413

2316

Presence of other devices

125

952

1.32

2.32

1.3

303.85

524.19

u/l

1.81

118

899

Dental pulpitis 4, only avohilmo

526

2396

1.15

2.31

1.3

382.70

485.37

u/l

1.42

501

2264

Gonarthrosis, primary, with knee surgery

220

2189

0.82

2.26

1.4

1.3

348.45

506.14

u/l

1.98

212

2067

Burns and corrosions of multiple body regions

3.95

2.26

1.0

1.2

418.57

340.33

u/l

—

Episodal and paroxysmal disorders

505

2256

1.15

2.25

1.3

330.63

510.80

u/l

4.02

467

2136

Nerve, nerve root and plexus disorders

492

2698

1.15

2.23

1.4

1.3

363.53

505.60

u/l

2.39

457

2560

Benign neoplasm: Rectum, anus and anal canal

107

804

1.34

2.22

1.4

1.3

923.22

346.68

u/l

0.46

100

757

Epilepsy

139

1082

1.28

2.18

1.3

429.43

488.82

u/l

0.31

133

1033

Cholecystectomy

327

2462

1.18

2.17

1.3

372.20

494.78

u/l

0.94

301

2339

Protein-energy malnutrition of moderate and mild degree

3.75

2.16

1.9

1.3

121.43

282.70

u/l

—

Colorectal cancer

130

1009

1.29

2.14

1.3

805.52

407.59

u/l

0.37

122

954

Alzheimer’s disease (Late onset)

1008

0.74

2.13

1.3

329.83

352.55

u/l

0.14

956

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

219

1767

1.21

2.12

1.4

1.3

448.55

554.49

u/l

0.58

206

1689

Low back pain

314

2054

1.18

2.12

1.3

484.26

482.57

u/l

0.01

292

1951

Psoriasis

118

906

1.31

2.11

1.3

584.83

378.58

u/l

0.44

109

861

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.96

2.09

1.1

1.5

388.30

237.65

u/l

—

Spondyloarthritis

572

1.38

2.08

1.2

1.3

1082.71

344.13

u/l

0.61

543

Nail disorders

176

1.71

2.05

1.4

1.3

254.10

364.11

u/l

1.04

169

Benign lipomatous neoplasm

661

1.35

2.01

1.3

420.25

370.26

u/l

0.24

625

Psoriasis vulgaris

593

1.37

2.01

1.4

1.3

674.64

373.83

u/l

0.45

569

Coxarthrosis

267

1524

1.19

2.00

1.4

1.3

332.30

522.16

u/l

1.58

252

1451

Follow-up examination after treatment for conditions other than malignant neoplasms

181

961

1.24

1.98

1.3

777.53

536.18

u/l

0.36

170

907

Soft tissue disorders related to use, overuse and pressure

116

899

1.29

1.96

1.4

1.3

760.92

525.29

u/l

0.24

109

857

Benign neoplasm of other and unspecified intrathoracic organs

3.00

1.94

1.8

1.2

227.00

279.68

u/l

—

Chronic laryngitis and laryngotracheitis

470

1.41

1.94

1.4

1.3

382.90

337.59

u/l

0.36

452

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

3.78

1.94

1.0

1.2

964.00

176.68

u/l

—

Malignant neoplasm of other and ill-defined digestive organs

3.24

1.89

1.3

1.4

435.14

342.57

u/l

—

Budesonide

283

1.52

1.89

1.4

1.3

223.35

347.70

u/l

2.22

270

Dental pulpitis 1, only avohilmo

520

2407

1.13

1.87

1.3

385.82

483.74

u/l

1.32

495

2274

Use of other anti-dementia drugs

106

1187

0.77

1.86

1.3

323.95

382.22

u/l

0.48

1117

Use of memantine

106

1187

0.77

1.86

1.3

323.95

382.22

u/l

0.48

1117

Colorectal adenocarcinoma

110

854

1.29

1.86

1.2

1.3

293.03

401.70

u/l

0.99

102

808

Dementia

189

1578

0.82

1.85

1.2

1.4

355.14

432.29

u/l

0.59

175

1494

Wet age-related macular degeneration

103

779

1.30

1.84

1.3

353.42

383.54

u/l

0.14

733

Maze procedure for atrial fibrillation

4.27

1.83

2.6

1.3

155.32

129.33

u/l

—

Other and unspecified medical devices associated with adverse incidents

4.26

1.83

1.0

1.1

325.20

224.38

u/l

—

Primary gonarthrosis, bilateral

195

2051

0.83

1.83

1.4

1.3

341.28

514.72

u/l

2.21

186

1938

Leukaemia of unspecified cell type

4.22

1.83

2.0

1.2

188.20

316.92

u/l

—

Papillary adenocarcinoma of thyroid gland

108

1.86

1.82

1.3

237.01

321.69

u/l

0.87

103

Benign neoplasm of middle ear and respiratory system

160

1.69

1.81

1.2

1.3

526.07

290.63

u/l

0.47

152

Appendectomy

225

1822

1.19

1.81

1.4

1.3

393.17

549.30

u/l

1.60

215

1733

Drug-induced polyneuropathy

3.09

1.81

1.0

1.3

690.71

225.64

u/l

—

Combinations of oral blood glucose lowering drugs

138

1108

1.25

1.78

1.4

1.3

259.02

557.00

u/l

3.23

130

1056

Other and unspecified disorders of vitreous body

122

1524

0.79

1.78

1.3

396.56

456.67

u/l

0.37

116

1451

Degenerative diseases of the nervous system

149

1380

0.81

1.77

1.2

1.3

531.58

393.23

u/l

0.48

134

1299

Non-selective monoamine reuptake inhibitors

175

1401

1.21

1.74

1.3

780.57

451.15

u/l

0.59

164

1332

Carcinoma in situ of rectum

2.97

1.73

1.3

258.71

297.36

u/l

—

Horner syndrome

2.95

1.73

1.6

1.2

438.00

354.26

u/l

—

Dissocial personality disorder

2.94

1.72

1.4

1.3

1007.86

297.96

u/l

—

Benign neoplasm: Ill-defined sites within the digestive system

3.91

1.72

1.0

1.1

329.00

299.02

u/l

—

Injuries to the shoulder and upper arm

372

2736

1.14

1.72

1.3

546.39

486.76

u/l

0.17

354

2585

Other disorders of bone

473

1.38

1.72

1.4

1.3

357.81

396.10

u/l

0.28

455

Orchitis and epididymitis

356

1.44

1.71

1.3

405.98

474.01

u/l

0.26

344

Hyperplasia of prostate

239

1153

1.18

1.71

1.4

1.3

369.12

622.48

u/l

2.10

224

1106

Tonsillectomy and adenotomy

744

0.76

1.70

1.3

516.96

458.47

u/l

0.28

712

Benign neoplasm: Rectum

700

1.30

1.68

1.5

1.3

1032.77

346.36

u/l

0.46

666

Subjective visual disturbances

718

1.30

1.67

1.4

1.3

276.69

375.08

u/l

1.57

677

Marginal zone B-cell lymphoma

3.20

1.67

1.3

166.53

272.02

u/l

—

Malignant melanoma

571

1.34

1.66

1.4

1.3

442.97

345.20

u/l

0.69

542

Polycystic ovarian syndrome, consortium definition

188

942

1.20

1.65

1.4

1.2

303.77

406.89

u/l

1.64

171

896

Dementia, including avohilmo

205

1676

0.84

1.65

1.2

1.3

355.05

439.56

u/l

0.70

192

1587

Melanocytic naevi

102

800

1.28

1.63

1.4

1.3

345.91

369.13

u/l

0.19

757

Otitis externa

625

1.31

1.62

1.3

601.71

356.46

u/l

0.68

599

Folate deficiency anaemia

3.61

1.62

1.2

1.5

111.00

313.95

u/l

—

All anxiety disorders

169

1126

1.21

1.61

1.3

711.93

417.17

u/l

1.08

159

1075

Other diseases of urinary system

471

2363

1.12

1.61

1.4

1.3

371.96

513.75

u/l

1.71

446

2239

Osteonecrosis due to drugs

2.53

1.60

1.5

1.3

317.50

337.13

u/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

687

1.30

1.60

1.3

387.04

376.45

u/l

0.07

659

Papulosquamous disorders

160

1324

1.21

1.59

1.4

1.3

517.77

469.94

u/l

0.11

149

1260

Abnormal serum enzyme levels

173

1426

1.20

1.57

1.3

1.4

396.83

553.73

u/l

0.86

163

1357

Myocardial infarction, with ST-elevation

109

869

1.26

1.55

1.4

1.3

448.30

376.34

u/l

0.20

103

818

Visual disturbances

191

1615

1.18

1.51

1.3

297.75

486.12

u/l

2.73

180

1527

Alzheimer’s disease (undefined)

0.00

1.50

0.0

1.2

—

272.11

—

Spinal stenosis

275

1873

1.15

1.50

1.4

1.3

422.67

483.22

u/l

0.30

260

1783

Benign neoplasm: Skin of other and unspecified parts of face

358

1.40

1.50

1.2

1.4

304.77

322.25

u/l

0.12

343

Anterior Iridocyclitis

600

1.30

1.48

1.3

378.44

355.47

u/l

0.21

576

Disorders of ocular muscles, binocular movement, accommodation and refraction

150

1234

1.21

1.47

1.4

1.3

493.83

415.98

u/l

0.25

140

1170

Use of donepezil

944

0.77

1.46

1.3

367.35

357.53

u/l

0.05

892

Melanoma of uvea

2.53

1.46

1.7

1.3

179.14

273.58

u/l

—

Alzheimer disease, excluding more controls

626

0.77

1.43

1.2

1.3

349.63

434.79

u/l

0.40

605

Urticaria and erythema

114

923

1.24

1.43

1.3

507.37

369.95

u/l

1.15

105

878

Other dorsopathies, not elsewhere classified

447

2114

1.12

1.42

1.3

417.04

495.23

u/l

0.62

421

2006

Polyuria

109

880

1.24

1.41

1.4

1.3

419.67

442.01

u/l

0.08

101

834

Malignant neoplasm of rectum

372

1.38

1.39

1.3

1595.09

337.24

u/l

0.46

351

Disorders of sclera, cornea, iris and ciliary body

210

1805

1.16

1.39

1.4

1.3

370.81

526.56

u/l

1.65

194

1713

Other disorders of urethra and urinary system

304

2006

1.14

1.38

1.3

403.85

476.56

u/l

0.48

280

1898

Malignant neoplasm of thyroid gland

150

1.61

1.38

1.3

1.4

264.63

336.16

u/l

0.64

144

Other injuries of upper limb, level unspecified

2.63

1.37

1.5

1.2

193.83

294.33

u/l

—

Abnormality of red blood cells

2.99

1.37

1.6

1.3

136.40

215.04

u/l

—

Iridocyclitis

714

1.26

1.36

1.3

386.73

374.10

u/l

0.09

679

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.97

1.36

1.2

1.1

368.60

303.80

u/l

—

Acute myeloid leukaemia, helper endpoint

2.97

1.36

1.2

1.1

368.60

303.80

u/l

—

Hypothyroidism, other/unspecified

383

2262

1.12

1.33

1.3

448.86

495.30

u/l

0.14

361

2141

Unspecified mental disorder

133

1105

1.20

1.32

1.2

1.3

544.76

370.43

u/l

2.92

125

1056

Polymyalgia rheumatica

506

1.31

1.2

1.3

818.59

304.32

u/l

1.03

477

Acute upper respiratory infections

462

2617

1.11

1.31

1.3

424.27

494.53

u/l

0.67

438

2472

Liposarcoma

2.54

1.31

1.0

1.4

237.83

251.38

u/l

—

Combined immunodeficiencies

2.52

1.31

1.8

1.3

230.72

270.36

u/l

—

Chronic hepatitis NAS

2.52

1.30

1.3

85.50

295.10

u/l

—

Burns and corrosions of multiple and unspecified body regions

2.10

1.30

1.0

1.3

417.11

280.39

u/l

—

Impaction of intestines

2.81

1.29

1.0

1.2

142.00

357.00

u/l

—

Malignant neoplasm of parotid gland

2.81

1.29

1.2

151.44

297.76

u/l

—

Myocardial infarction, unclassifiable

146

1094

1.19

1.28

1.3

250.73

413.03

u/l

2.50

132

1025

Kela-code for severe mental illness

122

1009

1.21

1.28

1.2

1.3

566.29

372.40

u/l

3.12

114

963

Alzheimer’s disease, wide definition, excluding more controls

580

0.77

1.28

1.3

339.04

444.90

u/l

0.57

561

Vertigo of central origin

2.06

1.27

1.2

1.3

462.26

316.88

u/l

—

Myalgia

579

1.28

1.27

1.4

1.3

394.71

405.89

u/l

0.04

555

Glaucoma

289

2247

1.13

1.26

1.3

466.48

462.72

u/l

0.01

266

2130

Recurring oral aphthae, including avohilmo

354

1.36

1.25

1.3

1.4

479.54

337.58

u/l

0.54

342

Bullous keratopathy

2.43

1.25

1.0

1.4

331.00

251.93

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

212

1.46

1.22

1.2

1.3

458.89

380.62

u/l

0.29

201

Habit and impulse disorders

2.64

1.22

1.2

698.02

448.93

u/l

—

Disorders of refraction and accommodation

563

1.28

1.22

1.4

1.3

295.56

386.62

u/l

1.31

540

Disorders of lacrimal system

164

1401

1.17

1.21

1.3

328.69

414.71

u/l

1.18

154

1323

Unspecified chronic bronchitis

116

1.65

1.21

1.6

1.3

509.74

330.26

u/l

0.57

109

Inflammatory bowel disease

111

916

1.21

1.4

1.3

308.49

379.12

u/l

1.04

106

873

Anxiety disorders, excluding more controls

300

1767

1.13

1.21

1.3

638.12

450.73

u/l

0.76

280

1685

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.33

1.19

1.2

1.3

274.97

287.72

u/l

—

Ductal carcinoma of pancreas

2.53

1.15

1.0

1.3

121.10

316.13

u/l

—

Malignant neoplasm of vulva

2.52

1.15

1.0

1.2

846.80

317.91

u/l

—

Other/unspecified dorsalgia

151

1283

1.17

1.14

1.4

1.3

363.00

541.64

u/l

1.49

144

1227

Hypothyreosis and Thyroxine purchase for inclusion criteria

392

2345

1.10

1.12

1.3

446.20

488.24

u/l

0.13

370

2225

Neurotic, stress-related and somatoform disorders

302

1921

1.12

1.11

1.3

649.13

500.51

u/l

0.55

281

1826

Acute alcohol intoxication, ICD10

610

1.25

1.10

1.2

1.4

842.77

373.48

u/l

1.06

586

Adenocarcinoma and papilloma adenocarcinoma of rectum

381

1.32

1.08

1.3

282.45

334.01

u/l

0.40

360

Fracture of skull and facial bones

620

1.24

1.08

1.2

1.3

810.09

390.54

u/l

0.60

597

Benign neoplasm: Oesophagus

2.21

1.08

1.1

1.3

339.00

294.04

u/l

—

Inguinal or femoral hernia, bilateral

487

1.28

1.08

1.5

1.3

325.01

409.91

u/l

0.44

460

Hypothyroidism, strict autoimmune, 3 medication purchases required

349

2151

1.11

1.07

1.3

472.38

493.85

u/l

0.05

329

2043

Alcohol induced polyneuropathy

2.14

1.06

1.3

1.4

133.29

297.19

u/l

—

Inguinal hernia, bilateral

480

1.27

1.05

1.5

1.3

328.66

412.23

u/l

0.42

453

Varicose veins

295

2003

1.11

1.04

1.4

1.3

380.53

480.30

u/l

0.77

280

1895

Other disorders of lacrimal gland

127

1080

1.18

1.04

1.4

1.3

290.66

406.39

u/l

2.10

119

1019

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

394

1.30

1.02

1.3

279.81

331.92

u/l

0.42

373

Any dementia

180

1448

0.87

1.01

1.2

1.4

369.03

456.58

u/l

0.59

165

1366

Diseases of male genital organs

277

1254

1.12

0.99

1.4

1.3

327.70

641.59

u/l

3.67

258

1201

Otosclerosis

237

0.63

0.99

1.3

1.4

301.27

328.48

u/l

0.13

231

Traction detachment of retina

2.19

0.98

1.2

1.3

205.60

283.10

u/l

—

Monoplegia

1.96

0.97

1.1

1.3

152.29

287.43

u/l

—

Erectile dysfunction

424

1.28

0.97

1.2

1.4

263.04

355.04

u/l

1.01

403

Other neurotic disorders

124

1.54

0.96

1.4

1.3

592.99

335.49

u/l

0.80

118

Lower back pain or/and sciatica

432

2757

1.09

0.95

1.3

460.53

495.06

u/l

0.21

405

2611

Melanoma in situ of other and unspecified parts of face

1.91

0.94

1.1

1.4

923.57

259.73

u/l

—

Other joint disorders

349

1693

1.10

0.93

1.4

1.3

397.50

538.39

u/l

1.42

324

1611

Acute and subacute iridocyclitis

570

1.23

0.93

1.3

351.14

365.45

u/l

0.12

547

Sleep disorders

498

1.25

0.93

1.3

397.95

360.95

u/l

0.22

478

Arthrosis

328

1638

1.10

0.93

1.3

482.86

519.47

u/l

0.10

309

1560

Traumatic ischaemia of muscle

2.16

0.92

1.0

1.3

4359.50

275.12

u/l

—

Hallux valgus (acquired)

100

856

0.84

0.91

1.4

1.3

353.43

411.75

u/l

0.51

816

Pruritus

278

1.33

0.91

1.4

1.3

289.59

322.36

u/l

0.21

269

Gonarthrosis,primary

381

2610

0.92

0.91

1.4

1.3

388.70

498.40

u/l

1.47

366

2462

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

126

1.51

0.91

1.5

1.3

683.11

346.12

u/l

0.82

121

Dental caries 2, only avohilmo

184

1639

0.88

0.91

1.3

594.25

554.51

u/l

0.11

175

1563

Neuromuscular dysfunction of bladder

296

1.32

0.90

1.2

1.4

347.15

338.50

u/l

0.04

284

Dorsopathies

449

2114

1.08

0.90

1.3

375.15

495.23

u/l

1.63

417

2006

Any dementia, excluding more controls

168

1324

0.88

0.90

1.2

1.3

368.60

438.16

u/l

0.42

156

1257

Other abnormal uterine and vaginal bleeding

452

1.22

0.89

1.3

191.62

365.01

u/l

3.13

430

Benign neoplasm of mouth and pharynx

332

1.30

0.89

1.2

1.4

259.22

325.86

u/l

0.61

319

Anxiety disorders

306

1973

1.10

0.88

1.3

644.46

494.88

u/l

0.57

285

1875

Oral lichen ruber planus, including avohilmo

128

0.55

0.88

1.7

1.3

281.43

328.19

u/l

—

122

Fracture at wrist and hand level

116

996

1.16

0.87

1.3

876.29

419.17

u/l

0.58

108

944

Crohn's disease of large intestine

1.61

0.87

1.5

1.2

183.29

342.23

u/l

2.29

Endometriosis diagnosis and infertility diagnosis occurring together

111

1.53

0.87

1.2

1.3

358.62

393.05

u/l

0.23

105

Leiomyoma of uterus

176

884

1.13

0.85

1.3

291.75

401.30

u/l

1.64

163

836

Type 1 diabetes, definitions combined

112

1.52

0.84

1.1

1.2

328.12

424.31

u/l

0.41

107

Prolapse and hernia of ovary and fallopian tube

136

0.58

0.83

1.1

1.2

186.82

247.44

u/l

—

129

Benign paroxysmal vertigo

1017

0.84

0.83

1.5

1.3

330.21

362.99

u/l

0.22

960

Benign neoplasm: Caecum

381

1.26

0.82

1.4

249.85

327.23

u/l

0.89

366

Headache

192

1433

1.12

0.82

1.4

1.3

310.77

542.76

u/l

2.76

181

1368

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

136

1267

0.88

0.82

1.4

1.3

318.44

405.16

u/l

1.39

129

1204

Pneumoconiosis due to asbestos and other mineral fibres

105

1.53

0.82

1.4

367.54

300.72

u/l

0.25

100

Benign neoplasm of brain and other parts of central nervous system

177

0.62

0.81

1.1

1.4

877.68

348.01

u/l

0.64

172

Parkinson's disease, strict definition

654

0.81

1.3

318.00

325.83

u/l

0.04

616

Other disorders of eyelid

214

1862

1.11

0.81

1.3

281.36

473.00

u/l

2.78

202

1763

Malignant melanoma of skin

418

1.25

0.80

1.3

1.4

484.34

322.06

u/l

0.99

398

Deep bite

144

0.61

0.80

1.2

1.4

479.10

343.00

u/l

—

136

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.78

0.0

1.2

—

249.36

—

Other symptoms and signs involving the nervous and musculoskeletal systems

152

1345

1.13

0.78

1.3

695.16

485.62

u/l

0.29

143

1277

Type 1 diabetes, strict (exclude DM2)

114

1.49

0.78

1.1

1.2

328.12

421.24

u/l

0.39

109

Ventral hernia

850

1.17

0.78

1.4

1.3

324.57

465.95

u/l

0.87

800

Haemorrhoids and perianal venous thrombosis

135

1185

1.14

0.78

1.3

333.81

500.31

u/l

1.41

127

1125

Injury of muscle and tendon at shoulder and upper arm level

126

1438

0.88

0.78

1.3

407.64

514.56

u/l

0.88

120

1369

Chondropathies

366

1.26

0.78

1.4

1.3

333.65

354.14

u/l

0.14

357

Coxibs

154

723

1.13

0.77

1.3

284.41

562.06

u/l

1.75

144

683

Other headache syndromes

104

1202

0.86

0.77

1.3

389.34

436.24

u/l

0.21

1155

Use of entacapone

0.00

0.76

0.0

1.4

—

253.65

—

Transport accidents

154

1211

1.13

0.76

1.3

699.30

496.15

u/l

0.29

146

1145

Congenital malformations of great arteries

2.14

0.75

2.0

1.2

364.40

384.37

u/l

—

Other specific joint derangements/joint disorders

260

1589

1.10

0.75

1.4

1.3

446.90

547.18

u/l

0.72

245

1514

Diseases of inner ear

194

2105

0.90

0.75

1.3

366.52

500.86

u/l

1.32

184

1994

Alzheimer’s disease (Late onset), excluding more controls

548

0.84

0.73

1.3

348.47

449.79

u/l

0.50

530

Other bacterial agents as the cause of diseases classified to other chapters

2.01

0.73

3.0

1.2

194.40

309.53

u/l

—

Keratitis

123

1081

1.14

0.72

1.3

363.38

391.21

u/l

0.18

114

1025

Maternal care for known or suspected abnormality of pelvic organs

168

0.70

0.72

1.2

1.3

310.53

398.73

u/l

0.57

158

Erosion of teeth, including avohilmo

410

1.23

0.72

1.5

1.4

402.81

347.85

u/l

0.25

390

Leukaemia of unspecified cell type

1.94

0.71

2.0

1.3

188.20

322.13

u/l

—

Gonarthrosis [arthrosis of knee](FG)

343

1869

1.08

0.70

1.4

1.3

396.13

534.02

u/l

1.44

326

1766

Benign lipomatous neoplasm

1031

0.86

0.70

1.3

420.25

373.32

u/l

0.25

977

Localized swelling, mass and lump of skin and subcutaneous tissue

119

1049

1.14

0.68

1.3

341.19

386.30

u/l

0.41

108

992

Other intervertebral disc disorders

365

2078

1.08

0.68

1.3

425.34

496.99

u/l

0.46

341

1973

Parkinson's disease

691

0.84

0.66

1.3

330.83

328.12

u/l

0.01

651

Acute alcohol intoxication

107

941

1.14

0.65

1.2

1.3

713.09

418.18

u/l

0.83

896

Somatoform disorder

367

1.23

0.65

1.3

1.4

1057.95

354.68

u/l

0.60

356

L02BX Other hormone antagonists and related agents

270

0.74

0.64

1.6

1.4

305.60

349.70

u/l

0.32

258

Hypopituitarism

137

1.39

0.64

1.2

1.4

388.32

368.76

u/l

0.09

131

Encephalopathy

1.73

0.64

1.0

1.4

465.80

281.94

u/l

—

Maternal care for other conditions predominantly related to pregnancy

186

0.69

0.62

1.5

1.3

401.61

431.20

u/l

0.10

173

Urticaria

682

1.16

0.62

1.3

478.69

358.37

u/l

0.82

644

Pain in joint

226

1372

1.09

0.62

1.4

1.3

449.97

578.15

u/l

0.86

211

1302

Blepharochalasis

126

1126

1.12

0.60

1.3

327.07

404.40

u/l

0.61

119

1057

Other or unspecified paralytic strabismus

0.00

0.60

0.0

1.3

—

282.52

—

Dermatographic urticaria

113

0.62

0.58

1.3

483.41

348.26

u/l

—

108

Diseases of the ear and mastoid process

491

2350

1.06

0.57

1.3

517.93

499.78

u/l

0.06

466

2223

Migraine without aura and triptan purchases

172

0.70

0.56

1.5

1.3

347.86

378.70

u/l

0.15

164

Oxicams

111

708

0.89

0.55

1.3

366.06

562.38

u/l

0.94

102

669

Other problems related to primary support group, including family circumstances

138

1.34

0.55

1.1

1.3

597.68

359.25

u/l

1.02

131

Acetic acid derivatives and related substances

153

722

1.10

0.54

1.3

597.23

561.51

u/l

0.05

142

682

Ulcerative colitis, NAS

348

1.21

0.54

1.3

354.10

368.49

u/l

0.07

335

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.58

0.54

1.2

1.3

234.50

316.48

u/l

—

Rotator cuff syndrome

273

1889

1.07

0.54

1.3

403.33

494.40

u/l

0.85

256

1789

Dislocation, sprain and strain of joints and ligaments of knee

152

1549

0.91

0.54

1.3

581.81

523.35

u/l

0.16

142

1486

Artificial joint operation, meniscal resection

382

2695

0.94

0.53

1.4

1.3

448.47

486.48

u/l

0.23

367

2545

Other disorders of choroid

1.54

0.53

1.2

1.3

3175.22

305.06

u/l

—

Seborrhoeic keratosis

844

1.13

0.53

1.4

1.3

566.77

341.35

u/l

0.56

799

Maternal care for known or suspected malpresentation of fetus

0.68

0.52

1.1

1.3

661.89

434.62

u/l

—

Fibromyalgia

146

0.68

0.52

1.2

547.60

301.27

u/l

—

141

Strabismus

694

1.14

0.51

1.4

1.3

672.37

361.47

u/l

0.70

664

Gonarthrosis

299

1606

1.07

0.51

1.3

405.04

517.44

u/l

0.97

284

1529

Striking against or struck by other objects

100

894

1.12

0.50

1.3

659.90

388.76

u/l

0.88

860

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.41

0.50

1.7

1.3

519.84

351.16

u/l

0.40

Parkinson's disease, including avohilmo

724

0.87

0.50

1.3

322.76

336.94

u/l

0.09

682

Cystitis

319

2074

0.94

0.50

1.3

333.97

497.46

u/l

2.20

305

1965

Contact with nonpowered hand tool

107

0.65

0.48

1.4

1.5

735.43

322.38

u/l

—

102

Benign neoplasm of urinary organs

137

1.32

0.47

1.4

1.3

638.28

341.20

u/l

0.56

132

Primary open-angle glaucoma

161

1445

1.09

0.47

1.3

527.41

428.89

u/l

0.20

148

1362

Persons encountering health services in circumstances related to reproduction

118

881

0.91

0.46

1.3

339.94

521.31

u/l

2.66

112

837

LSIL lesion of the cervix uteri

117

0.68

0.45

1.1

1.3

193.46

404.01

u/l

—

112

Vasomotor and allergic rhinitis

905

0.89

0.45

1.3

887.87

407.70

u/l

0.59

862

Other diseases of hard tissues of teeth

225

1567

1.07

0.45

1.4

1.3

418.30

432.41

u/l

0.10

213

1487

Pedal cyclist injured in noncollision transport accidents

253

0.79

0.44

1.4

2685.25

351.82

u/l

0.52

242

Female infertility

318

0.85

0.44

1.1

1.3

732.11

457.07

u/l

0.31

305

Oter anti-inflammatory and antirheumatic agents, non-steroids

137

696

1.09

0.43

1.4

1.3

309.77

564.39

u/l

1.43

131

659

Organic, including symptomatic, mental disorders

267

1814

1.06

0.43

1.2

1.4

486.72

425.20

u/l

0.23

253

1724

Disorders of synovium and tendon

165

1603

0.93

0.43

1.4

1.3

488.51

519.87

u/l

0.12

157

1517

Mood [affective] disorders

356

2465

0.95

0.42

1.3

634.17

494.04

u/l

0.69

334

2337

Prolonged pregnancy

1.35

0.42

1.3

709.29

395.01

u/l

0.76

Diseases of middle ear and mastoid

169

1284

1.08

0.42

1.3

505.15

515.31

u/l

0.03

161

1215

Acute myeloid leukaemia

1.52

0.41

1.2

1.3

368.60

330.55

u/l

—

Malignant neoplasm of gallbladder

0.00

0.41

0.0

1.3

—

214.95

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.3

—

354.33

—

Cutis laxa senilis

0.00

0.41

0.0

1.1

—

298.75

—

Deforming dorsopathies

870

1.10

0.41

1.4

1.3

823.20

407.31

u/l

0.85

837

Frontotemporal dementia

0.00

0.41

0.0

1.4

—

319.89

—

Factitial dermatitis

0.00

0.41

0.0

1.4

—

342.96

—

Autism spe

0.00

0.41

0.0

1.1

—

486.07

—

Single delivery by forceps and vacuum extractor

0.72

0.41

1.1

1.3

386.20

469.67

u/l

—

Disorders of vestibular function (Vertigo)

166

1771

0.93

0.40

1.4

1.3

392.85

449.78

u/l

0.38

157

1678

Malignant neoplasm of testis

1.47

0.40

2.0

1.5

325.60

313.88

u/l

—

Glaucoma, exfoliation

464

1.14

0.40

1.3

1096.25

307.82

u/l

0.71

436

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.40

0.0

1.7

—

310.29

—

Hereditary motor and sensory neuropathy

0.00

0.40

0.0

1.4

—

176.87

—

Overjet

0.00

0.40

0.0

1.2

—

402.43

—

Benign neoplasm: Eye, unspecified

0.00

0.39

0.0

1.4

—

235.77

—

Follicular adenocarcinoma of thyroid gland

0.00

0.39

0.0

1.3

—

299.70

—

Hypermetropia

142

1.27

0.38

1.4

1.3

181.93

361.12

u/l

3.82

136

Postprocedural disorders of nervous system

1.33

0.37

1.2

1.3

445.76

305.11

u/l

0.52

Migraine with aura and triptan purchases

180

0.78

0.36

1.5

1.3

258.02

349.58

u/l

0.89

171

malignant neoplasm of male genital organs

258

1552

1.06

0.36

1.4

1.3

488.33

540.79

u/l

0.15

243

1471

Unspecified urinary incontinence

235

1.19

0.36

1.5

1.3

260.03

308.93

u/l

0.38

227

Cerebral atherosclerosis

1.43

0.35

1.2

1.4

228.67

239.81

u/l

—

Mood disorders

360

2472

0.96

0.35

1.3

630.43

493.23

u/l

0.68

338

2344

Haemorrhage in early pregnancy

405

0.87

0.34

1.2

1.3

592.28

421.05

u/l

0.70

382

Acute appendicitis, no complications

152

1619

0.94

0.34

1.4

1.3

441.18

594.20

u/l

1.15

146

1538

Inflammatory diseases of prostate (prostatitis)

576

1.11

0.34

1.4

1.3

280.94

654.80

u/l

2.15

556

Glaucoma suspect

152

1423

1.07

0.33

1.3

391.47

444.59

u/l

0.16

143

1342

Premature rupture of membranes

139

0.79

0.33

1.1

1.3

591.79

406.12

u/l

0.44

130

Parkinson's disease, strict definition, excluding more controls

582

0.89

0.33

1.3

318.00

476.78

u/l

0.86

561

Chronic sinusitis

146

1367

1.07

0.32

1.5

1.3

527.48

548.63

u/l

0.06

137

1305

Other degenerative diseases of the nervous system

125

884

1.07

0.30

1.2

1.3

912.34

510.39

u/l

0.48

116

849

Primary open-angle glaucoma, strict

126

1175

1.07

0.30

1.3

257.54

394.56

u/l

2.07

117

1104

Polyp of the female genital tract

489

0.92

0.29

1.4

1.2

511.32

389.41

u/l

0.56

464

Early lumbar disc prolapse operation

139

1.22

0.29

1.3

625.00

369.85

u/l

0.71

133

Retinal breaks without detachment

499

1.10

0.27

1.3

355.94

359.50

u/l

0.02

476

Antepartum haemorrhage, not elsewhere classified

1.23

0.27

1.0

1.2

506.75

382.81

u/l

—

Disorders of breast

114

990

1.07

0.26

1.2

1.3

405.21

388.05

u/l

0.10

106

939

Other diseases of upper respiratory tract

502

2538

1.03

0.26

1.4

1.3

457.87

485.09

u/l

0.17

474

2407

Allergic rhinitis

546

0.91

0.26

1.3

1257.95

394.39

u/l

0.67

527

Parkinson's disease, excluding more controls

618

0.91

0.25

1.3

330.83

467.72

u/l

0.77

593

Other appendicitis

197

1.17

0.25

1.8

1.4

293.91

352.76

u/l

0.41

190

Impingement syndrome of shoulder

858

1.07

0.25

1.3

312.80

567.78

u/l

2.05

820

Female infertility, cervigal, vaginal, other or unspecified origin

313

0.90

0.25

1.1

1.3

787.48

459.22

u/l

0.36

300

Nontraumatic intracranial haemmorrhage

850

1.07

0.24

1.3

404.43

402.64

u/l

0.01

804

Artificial joint re-operation

227

1.15

0.23

1.6

1.3

331.69

318.99

u/l

0.04

220

Other enthesopathies

900

1.07

0.23

1.5

1.3

344.65

434.87

u/l

1.09

860

Deviated nasal septum

121

1278

0.95

0.23

1.4

1.3

603.63

546.38

u/l

0.15

112

1221

Noninflammatory disorders of female genital tract

505

0.94

0.22

1.2

344.99

391.59

u/l

0.36

479

Dental caries 2

205

1678

0.96

0.22

1.3

577.49

555.81

u/l

0.06

195

1601

Other sudden death, cause unknown

0.00

0.21

0.0

1.5

—

146.09

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.5

—

144.33

—

Carcinoma in situ of oral cavity

0.00

0.21

0.0

1.3

—

142.96

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.4

—

200.50

—

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

1.3

—

232.42

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.3

—

203.07

—

Other and unspecified pemphigus

0.00

0.21

0.0

1.4

—

244.67

—

Other cestode infections

0.00

0.21

0.0

1.1

—

202.33

—

Injury of nerves at hip and thigh level

0.00

0.21

0.0

1.4

—

128.97

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.6

—

183.80

—

Mucinous and mucinous cystic tumor

0.00

0.21

0.0

1.0

—

245.75

—

Ankylosis of joint

0.00

0.21

0.0

1.1

—

236.15

—

Other and unspecified papulosquamous disorders

0.00

0.21

0.0

1.4

—

152.79

—

Other and unspecified injuries of forearm

0.00

0.21

0.0

1.4

—

168.50

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.21

0.0

1.2

—

541.27

—

Gender identity disorders

0.00

0.21

0.0

1.3

—

543.80

—

Disorders of puberty, all

0.00

0.21

0.0

1.2

—

506.87

—

Adenocarcinoma of small intestine

0.00

0.21

0.0

1.4

—

150.03

—

Idiopathic peripheral autonomic neuropathy

0.00

0.21

0.0

1.3

—

147.55

—

Other and unspecified neuropathies

0.00

0.21

0.0

1.4

—

227.73

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.3

—

180.53

—

Ulcerative rectosigmoiditis

182

1.15

0.21

1.3

1.4

336.19

362.68

u/l

0.14

174

Meniscus derangement

219

1557

0.96

0.21

1.3

465.96

524.78

u/l

0.22

205

1484

Other disorders following mastoidectomy

0.00

0.21

0.0

1.1

—

201.05

—

Senile degeneration of the brain, not elsewhere classified

0.00

0.21

0.0

1.4

—

327.62

—

Chromophobe cell carcinoma of kidney

0.00

0.21

0.0

1.3

—

197.43

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.4

—

372.08

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.5

—

408.33

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.21

0.0

1.3

—

233.33

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

143

0.86

0.21

1.3

335.63

439.14

u/l

0.54

137

Disorders of conjunctiva

253

2192

0.97

0.20

1.3

399.63

529.34

u/l

1.44

239

2076

Malignant neoplasm of prostate

253

1542

1.04

0.20

1.4

1.3

491.45

542.31

u/l

0.14

238

1461

Other secondary gonarthrosis

145

1.17

0.20

1.3

1.4

374.47

346.53

u/l

0.07

139

Tooth eruption problems

125

1.19

0.20

1.2

1.3

757.13

390.81

u/l

0.40

119

UC patients in KELA-register (code 208), prior to 1994

123

0.81

0.20

1.2

1.3

314.10

349.67

u/l

—

116

Adrenogenital disorders

0.00

0.20

0.0

1.4

—

203.86

—

Redundant prepuce, phimosis and paraphimosis

680

1.07

0.20

1.4

1.3

492.87

582.91

u/l

0.16

652

Urolithiasis

136

1424

0.95

0.20

1.4

1.3

419.71

557.70

u/l

0.53

127

1357

Allergic conjunctivitis

132

1360

0.95

0.19

1.4

1.3

429.12

399.50

u/l

0.21

125

1294

Use of pramipexole

782

1.06

0.19

1.3

351.23

338.44

u/l

0.08

738

Maternal care for other known or suspected fetal problems

113

0.85

0.19

1.7

1.3

288.73

445.14

u/l

1.12

107

conjunctival haemorrhage

241

1.12

0.19

1.7

1.3

256.99

327.91

u/l

0.55

230

Nontoxic single thyroid nodule

175

0.86

0.18

1.7

1.4

294.53

329.92

u/l

0.15

170

Lichen sclerosus et atrophicus

217

0.87

0.18

1.7

1.3

330.82

309.71

u/l

0.08

208

Other and/or unspecified nontoxic goitre

213

1.13

0.18

1.3

1.4

315.42

325.76

u/l

0.06

205

Acute appendicitis

237

2165

1.03

0.18

1.4

1.3

392.71

555.63

u/l

1.93

227

2055

Coxarthrosis, primary

288

2429

1.03

0.17

1.4

1.3

334.43

487.21

u/l

1.55

274

2298

Medical treatment for female infertility

166

1.14

0.17

1.2

1.3

1280.46

444.35

u/l

0.44

156

Oral leukoplakia and related diseases

157

1.15

0.17

1.4

1.3

426.99

363.27

u/l

0.19

151

Cervical disc disorders

133

1387

0.96

0.17

1.4

1.3

416.79

545.61

u/l

0.81

126

1323

Inflammatory diseases of female pelvic organs

135

975

1.04

0.17

1.2

1.3

380.31

396.87

u/l

0.11

126

924

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

927

0.95

0.17

1.4

1.3

480.35

387.34

u/l

0.30

883

Other disorders of cornea

263

1.10

0.16

1.2

1.4

478.79

325.32

u/l

0.29

256

Postpartum haemorrhage

205

0.89

0.16

1.2

1.3

305.00

445.17

u/l

1.64

195

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

127

1298

0.96

0.15

1.3

439.25

400.52

u/l

0.28

120

1234

Cervicocranial syndrome

276

0.91

0.15

1.5

1.3

439.80

310.12

u/l

0.68

266

Dental caries 2 and operation codes

200

1638

0.97

0.15

1.3

582.20

559.56

u/l

0.06

190

1562

Alzheimer’s disease (Atypical or mixed)

419

0.93

0.15

1.3

392.32

357.65

u/l

0.09

398

Recurrent or chronic depression

711

0.95

0.15

1.3

830.88

426.78

u/l

0.73

678

Macular hole

188

1.12

0.14

1.1

1.4

411.48

331.56

u/l

0.51

181

Cluster headache, wide,, including avohilmo

0.79

0.14

1.0

1.3

451.29

337.65

u/l

—

Other arthrosis

218

1516

1.03

0.14

1.4

1.3

653.75

524.29

u/l

0.26

199

1443

Synovial cyst of popliteal space [Baker]

227

1.10

0.14

1.4

1401.82

303.15

u/l

0.57

219

Menorrhagia

497

1.05

0.14

1.5

1.2

300.66

387.38

u/l

0.78

471

Glucosamine medication

224

1832

0.98

0.12

1.4

1.3

272.37

470.26

u/l

3.25

210

1736

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

716

1.05

0.12

1.3

367.56

401.71

u/l

0.28

688

Mood disorders, excluding more controls

356

2125

1.02

0.12

1.3

629.92

447.86

u/l

1.02

334

2024

Extrapyramidal and movement disorders

146

1504

0.97

0.12

1.3

354.00

484.51

u/l

1.13

136

1423

Anti-inflammatory and antirheumatic products, non-steroids

140

725

0.97

0.11

1.3

370.76

561.59

u/l

0.93

135

685

Selective serotonin reuptake inhibitors

433

2243

1.02

0.11

1.3

610.40

454.31

u/l

0.65

409

2130

Endovascular or surgical operations to intracerebral aneurysms

163

1.11

0.10

1.3

1.4

464.64

340.00

u/l

0.50

156

LSIL lesion of the cervix uteri, vagina or vulva

167

0.90

0.10

1.1

1.3

216.98

370.12

u/l

2.22

160

Depression or dysthymia

296

1625

1.02

0.10

1.4

1.3

510.74

460.20

u/l

0.22

278

1548

Appendicitis, broad definition

256

2294

1.02

0.10

1.4

1.3

385.48

556.69

u/l

2.28

246

2177

Benign neoplasm of middle ear and respiratory system

251

1.08

0.10

1.2

1.3

526.07

350.60

u/l

0.33

242

Diseases of tongue

183

1.09

0.10

1.5

1.4

255.13

342.13

u/l

0.83

178

Endometriosis

494

0.96

0.10

1.4

1.2

472.71

390.42

u/l

0.39

468

Conjunctivitis

211

1876

0.98

0.09

1.3

426.81

422.85

u/l

0.03

199

1776

Pregnancy with abortive outcome

156

836

0.98

0.09

1.4

1.3

441.51

382.71

u/l

0.19

148

790

Other obstetric conditions, not elsewhere classified

148

0.92

0.09

1.3

466.85

444.43

u/l

0.05

142

Simple and mucopurulent chronic bronchitis

145

1.10

0.09

1.7

1.3

482.31

312.98

u/l

0.25

138

Medical abortion

155

822

1.02

0.09

1.3

412.33

385.11

u/l

0.08

149

777

Carpal tunnel syndrome

215

1977

0.98

0.09

1.4

1.3

377.17

546.29

u/l

1.36

200

1879

Diseases of appendix

258

2311

1.02

0.08

1.4

1.3

384.44

553.74

u/l

2.26

247

2194

Alzheimer’s disease (Atypical or mixed), excluding more controls

346

0.95

0.08

1.2

1.3

402.45

478.96

u/l

0.18

335

Mixed and other personality disorders

117

1.11

0.08

1.2

1.5

3778.01

351.94

u/l

0.48

109

Irritable bowel syndrome

722

0.97

0.07

1.3

322.46

392.75

u/l

0.67

688

Injury of muscle and tendon at hip and thigh level

245

1.06

0.07

1.7

1.4

306.80

339.61

u/l

0.16

236

Other hammer toe(s) (acquired)

591

0.97

0.07

1.4

1.3

334.72

375.15

u/l

0.31

561

Excessive vomiting in pregnancy

0.89

0.06

1.4

1.3

395.38

371.04

u/l

—

Postpartum haemorrhage due to retained placenta

0.84

0.06

1.3

1.4

327.25

407.46

u/l

—

Postpartum hemorraghe, all women as controls

223

0.94

0.06

1.2

1.3

305.00

461.23

u/l

1.95

210

Perineal laceration during delivery

0.87

0.06

1.3

366.89

391.76

u/l

—

Other acquired deformities of musculoskeletal system and connective tissue

109

1.10

0.06

1.4

390.00

308.22

u/l

0.65

104

Mucosal proctocolitis

266

1.05

0.06

1.4

312.00

362.69

u/l

0.27

255

Maternal care for known or suspected fetal abnormality and damage

1.10

0.06

1.3

1.2

498.67

444.66

u/l

0.10

Calculus of kidney and ureter

126

1283

0.98

0.05

1.4

1.3

314.33

509.98

u/l

1.86

118

1221

Internal derangement of knee

132

1298

1.01

0.04

1.4

1.3

439.73

559.22

u/l

0.34

123

1242

Mouth breathing

140

1380

1.01

0.04

1.3

462.46

565.89

u/l

0.51

127

1321

Depression

325

2255

0.99

0.04

1.3

649.40

500.79

u/l

0.67

306

2136

Struck by thrown, projected or falling objec

101

1.09

0.04

1.5

1.4

339.47

311.04

u/l

0.08

Other/unspecified disorders of vestibular function

111

1.08

0.04

1.2

1.3

196.86

279.76

u/l

0.82

106

Supervision of normal pregnancy

114

1.05

0.03

1.1

1.2

255.38

423.83

u/l

2.38

105

Lumbar disc prolapse

237

1900

0.99

0.03

1.4

1.3

391.26

511.67

u/l

1.22

225

1809

Disorders of vitreous body

189

1868

0.99

0.03

1.3

357.64

481.43

u/l

1.33

181

1773

Injuries to the wrist and hand

361

2633

0.99

0.03

1.3

586.39

479.10

u/l

0.27

345

2488

Flat foot [pes planus] (acquired)

229

0.96

0.02

1.3

596.23

325.48

u/l

0.49

217

Trigger finger

390

1.03

0.02

1.5

1.3

377.98

340.46

u/l

0.22

376

Migraine without aura

239

0.96

0.02

1.5

1.3

480.84

379.05

u/l

0.47

234

Disorders of vitreous body and globe

200

1935

1.01

0.02

1.3

350.20

498.79

u/l

1.68

192

1836

Brain meningioma

128

0.94

0.02

1.1

1.3

456.00

320.90

u/l

0.27

122

Sciatica+with lumbago

173

1656

0.99

0.02

1.4

1.3

402.58

519.43

u/l

0.89

163

1579

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

655

1.01

0.02

1.4

1.3

358.60

431.99

u/l

0.46

626

Other noninflammatory disorders of uterus, except cervix

450

1.02

0.02

1.2

1.3

345.62

358.46

u/l

0.04

428

Malignant neoplasm of bladder

348

0.98

0.01

1.4

1.3

325.89

431.57

u/l

0.36

327

D07AA Corticosteroids, weak (group I)

312

1.02

0.01

1.3

405.88

342.97

u/l

0.25

302

Tongue abnormality

163

1.04

0.01

1.6

1.3

233.08

338.13

u/l

0.97

157

Spondylosis

223

1904

1.00

0.01

1.3

553.85

485.35

u/l

0.27

208

1811

Hallux rigidus

487

0.99

0.01

1.4

1.3

353.92

395.09

u/l

0.26

467

Irregular menses

605

0.99

0.00

1.4

1.3

376.12

461.16

u/l

0.54

579

Ectopic pregnancy

267

1.01

0.00

1.4

1.3

429.04

481.87

u/l

0.14

254

Fall on same level involving ice and snow

195

1954

1.00

0.00

1.3

473.54

536.84

u/l

0.18

183

1856

Artrosis, including avohilmo

372

2041

1.00

0.00

1.3

493.96

515.28

u/l

0.07

351

1936

Coxarthrosis, primary, with hip surgery

222

2107

1.00

0.00

1.4

1.3

339.50

455.38

u/l

0.82

210

1991

Other disorders of amniotic fluid and membranes

1.01

0.00

1.4

1.3

331.50

406.79

u/l

—

Carcinoma in situ of cervix uteri

1.02

0.00

1.1

1.3

176.37

351.89

u/l

—

Calcific tendinitis of shoulder

141

0.99

0.00

1.3

1.4

251.21

313.22

u/l

0.56

136

Excessive attrition of teeth

110

595

1.00

0.00

1.3

384.56

398.51

u/l

0.09

103

562

Excessive, frequent and irregular menstruation

504

1.00

0.00

1.4

1.2

313.93

390.46

u/l

0.69

478

Postpartum hemorraghe, parous women as controls

179

1.03

0.00

1.2

1.3

305.00

419.56

u/l

1.17

172

Foreign body or object entering through skin

134

0.97

0.00

1.2

1.4

531.14

396.35

u/l

0.61

128

Antenatal screening

115

0.98

0.00

1.3

1.2

397.40

426.47

u/l

0.09

106

Other specified and unspecified retinal disorders

101

0.99

0.00

1.4

105.60

306.45

u/l

—

Lateral epicondylitis

329

1.00

0.00

1.7

1.3

392.23

396.98

u/l

0.02

320

Ménière disease

304

0.99

0.00

1.3

1.4

396.52

307.32

u/l

0.49

294

Acute laryngitis and tracheitis

139

0.99

0.00

1.3

433.07

382.27

u/l

0.19

133

Nonspecific lymphadenitis

107

1.03

0.00

1.8

1.3

230.55

339.26

u/l

0.89

101

Supervision of high-risk pregnancy

113

1.02

0.00

1.2

358.58

416.63

u/l

0.19

105

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.2

—

214.60

—

Pediculosis and phthiriasis

0.00

0.0

1.2

—

143.60

—

Mastocytosis

0.00

0.0

1.4

—

223.08

—

Choroidal haemorrhage and rupture

0.00

0.0

1.4

—

323.82

—

Other obstructed labour

0.93

0.00

1.9

1.3

168.89

436.50

u/l

—

Disorders of adrenal gland, other and/or unspecified

0.00

0.0

1.2

—

270.63

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.3

—

209.43

—

Injury of blood vessels at forearm level

0.00

0.0

1.6

—

146.38

—

Actinic reticuloid

0.00

0.0

1.5

—

133.83

—

Autism spe, excluding more controls

0.00

0.0

1.2

—

315.33

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.2

—

189.55

—

Injury of blood vessels at neck level

0.00

0.0

1.4

—

396.91

—

Enterobiasis

0.00

0.0

1.2

—

263.60

—

Merkel cell carcinoma of skin

0.00

0.0

1.6

—

131.72

—

Degenerative and vascular disorders of ear

0.00

0.0

1.1

—

242.10

—

Maxillary prognathism

0.00

0.0

1.1

—

531.43

—

Other specified acquired deformities of limbs

0.00

0.0

1.0

—

188.59

—

Flexion deformity

0.00

0.0

1.0

—

211.74

—

Fatigue fracture of vertebra

0.00

0.0

1.2

—

161.56

—

Hereditary nephropathy, not elsewhere classified

0.00

0.0

1.1

—

157.23

—

Calcium deposit in bursa

0.00

0.0

1.1

—

184.39

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.4

—

739.00

—

Onychogryphosis

0.00

0.0

1.3

—

207.04

—

Other hypertrichosis

0.00

0.0

1.0

—

213.14

—

Generalized pustular psoriasis

0.00

0.0

1.5

—

160.63

—

Acanthosis nigricans

0.00

0.0

1.2

—

176.50

—

Acne conglobata

0.00

0.0

1.2

—

247.93

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.0

1.2

—

179.80

—

Precocious central puberty

0.00

0.0

1.2

—

301.95

—

Polyp of middle ear

0.00

0.0

1.2

—

188.92

—

Other and unspecified disorders of refraction

0.00

0.0

1.3

—

233.17

—

Disorders of acoustic nerve

0.00

0.0

1.0

—

184.40

—

Juvenile Open Angle Glaucoma

0.00

0.0

1.3

—

158.14

—

Acute lymphocytic leukaemia, helper endpoint

0.00

0.0

1.2

—

516.00

—

Lens-induced iridocyclitis

0.00

0.0

1.6

—

160.33

—

Phantom limb syndrome

0.00

0.0

1.6

—

117.60

—

Disorders in reading

0.00

0.0

1.1

—

481.11

—

Familial chondrocalcinosis

0.00

0.0

1.2

—

188.32

—

Diseases of thymus

0.00

0.0

1.2

—

206.80

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.4

—

144.72

—

Hyperalimentation, other specified

0.00

0.0

1.2

—

141.38

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.5

—

214.67

—

Drug-induced aplastic anaemia

0.00

0.0

1.2

—

135.60

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

1.3

—

145.77

—

Postinfectious hypothyroidism

0.00

0.0

1.0

—

172.51

—

Qualitative platelet defects

0.00

0.0

1.1

—

214.34

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.1

—

156.94

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.4

—

139.80

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.2

—

115.32

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

1.5

—

194.63

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.2

—

349.29

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.5

—

187.50

—

Benign neoplasm: Urethra

0.00

0.0

1.3

—

206.33

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

213.80

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.2

—

197.62

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.3

—

200.83

—

Impacted maxillary canine

0.00

0.0

1.4

—

312.66

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

0.0

1.0

—

247.86

—

Benign neoplasm: Mediastinum

0.00

0.0

1.3

—

135.20

—

Rickettsioses

0.00

0.0

1.4

—

162.88

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.1

—

166.81

—

Disorders of puberty

0.00

0.0

1.3

—

491.09

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.3

—

203.50

—

Chloasma

0.00

0.0

1.2

—

134.00

—

Congenital hydrocephalus

0.00

0.0

1.6

—

133.40

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

114.00

—

Colour vision deficiencies

0.00

0.0

1.1

—

223.33

—

Whooping cough

0.00

0.0

1.2

—

200.00

—

Traumatic subcutaneous emphysema

0.00

0.0

1.5

—

157.83

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.1

—

264.57

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.6

—

167.32

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

516.00

—

Other porphyria

0.00

0.0

1.0

—

266.14

—

Thyrotoxicosis factitia

0.00

0.0

1.0

—

118.12

—

Vitreous prolapse

0.00

0.0

1.2

—

168.34

—

Superficial injury of ankle and foot, unspecified

0.00

0.0

1.0

—

161.77

—

Other dermatomyositis

0.00

0.0

1.1

—

204.07

—

Nutritional marasmus

0.00

0.0

1.4

—

233.40

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

0.0

1.2

—

980.40

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.2

—

176.80

—

Toxic encephalopathy

0.00

0.0

1.3

—

180.29

—

Thalassaemia

0.00

0.0

1.0

—

243.71

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.6

—

149.78

—

Hypospadias

0.00

0.0

1.4

—

614.60

—

Lichen planopilaris

0.00

0.0

1.4

—

194.20

—

Brain astrocytoma

0.00

0.0

1.3

—

229.67

—

Corneal pigmentations and deposits

0.00

0.0

1.3

—

220.07

—

Severe bullous disorders, KELA reimbursement

0.00

0.0

1.2

—

275.94

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.4

—

212.60

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

553.29

—

Carcinoma in situ of oral cavity

0.00

0.0

1.3

—

452.50

—

Relapsing fevers

0.00

0.0

1.3

—

196.86

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.4

—

220.13

—

Benign neoplasm: Orbit, unspecified

0.00

0.0

1.3

—

208.67

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.0

1.0

—

376.14

—

Pelvic region

0.00

0.0

1.2

—

164.92

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.1

—

230.57

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.1

—

197.09

—

Nonadministration of surgical and medical care

0.00

0.0

1.6

—

178.40

—

Fall involving playground equipment

0.00

0.0

1.3

—

226.27

—

Foreign object accidentally left in body during surgical and medical care

0.00

0.0

1.1

—

202.07

—

Discharge from other and unspecified firearms

0.00

0.0

1.2

—

182.80

—

General hospital and personal-use devices associated with adverse incidents

0.00

0.0

1.6

—

213.00

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.1

—

206.67

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.0

1.1

—

193.81

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.6

—

172.00

—

Explosion of other materials

0.00

0.0

1.5

—

153.00

—

Sequelae of burns, corrosions and frostbite

0.00

0.0

1.3

—

217.48

—

Other injuries of spine and trunk, level unspecified

0.00

0.0

1.1

—

477.50

—

Vaginal lichen planus

0.00

0.0

1.2

—

241.92

—

Other superficial injuries of ankle and foot

0.00

0.0

1.3

—

192.78

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.2

—

234.60

—

Fractures involving multiple body regions

0.00

0.0

1.3

—

230.00

—

Other congenital malformations of kidney

0.00

0.0

1.0

—

197.29

—

Other congenital malformations of male genital organs

0.00

0.0

1.2

—

610.20

—

Use of trihexyphenidyl

0.00

0.0

1.3

—

215.17

—

Use of bromocriptine

0.00

0.0

1.3

—

205.93

—

Phantom limb syndrome with pain

0.00

0.0

1.5

—

94.50

—

Use of pergolide

0.00

0.0

1.6

—

129.00

—

Infliximab

0.00

0.0

1.2

—

524.67

—

Small kidney of unknown cause

0.00

0.0

1.3

—

227.59

—

Traumatic spondylopathy

0.00

0.0

1.5

—

136.21

—

Use of riluzole

0.00

0.0

1.4

—

198.33

—

Interstitial myositis

0.00

0.0

1.2

—

251.34

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.4

—

203.14

—

Acute lymphocytic leukaemia

0.00

0.0

1.2

—

197.20

—

Other and unspecified syphilis

0.00

0.0

1.3

—

201.67

—

Other infestations

0.00

0.0

1.4

—

130.72

—

Plasmodium falciparum malaria

0.00

0.0

1.2

—

253.00

—

0.00

-0.00

0.0

1.1

—

205.86

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.2

—

266.80

—

Congenital retinoschisis

0.00

-0.00

0.0

1.3

—

143.13

—

Toxic erythema

0.00

-0.00

0.0

1.4

—

201.12

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS